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Abstract 
Studies of a site-specific recombination system and analysis of new 
modulators of Notch signaling in C. elegans. 
 
Marcus L. Vargas 
	  
The ability to make transgenic animals has been a great tool for biologists to study 
living organisms. In C. elegans, the way transgenes are generated makes them 
problematic in many circumstances, and there is no single, simple, reliable approach that 
circumvents all of the problems with current methods of introducing transgenes into C. 
elegans. In Chapter 2, I discuss my attempt to develop a transgenic system in C. elegans 
using the bacteriophage φC31 integrase system. I show evidence that φC31 integrase is 
active in C. elegans somatic tissue. I have successfully integrated a transgene into the C. 
elegans genome in single-copy using φC31 dependent recombination-mediated cassette 
exchange. However, attempts to repeat φC31-mediated integration has been unsuccessful. 
In Chapter 3, I use genetic analysis to test many genes that were reported to be 
associated with the γ-secretase complex in a mammalian tissue culture system. The γ-
secretase complex is an important component in the Notch signaling pathway. Not only is 
the γ-secretase complex essential in the Notch pathway, it is also implicated in the 
pathology of familial Alzeheimer’s disease (FAD). As γ-secretase complex components 
show a Notch loss-of-function phenotype in C. elegans, a reverse genetic approach, using 
genes encoding proteins that associate with Presenilin was used to identify putative new 
Notch modulators. Several genes were identified that suppress a glp-1(gf) allele and one 
gene that suppress a gfp-1(lf) allele. These genes are unlikely to be core components of 
the Notch signaling pathway. 
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During the evolution of metazoans, as organisms have undergone the transition 
from unicellularity to multicellularity, mechanisms that allow cells to communicate with 
other came into existence. These mechanisms allowed cells to organize and to coordinate 
with each other to ensure the survival of multicellular organisms. There are a handful of 
conserved signaling pathways, which are used iteratively and repetitively, that contributes 
to the diversity seen in the metazoan lineage. One such signaling pathway is the Notch 
pathway.  
In metazoans, not only is Notch highly conserved, but the signaling transduction 
pathway is conserved as well (Eve Gazave 2009). There are two C. elegans Notch 
orthologues, LIN-12 and GLP-1, there is one D. melanogaster Notch and there are four 
Notch orthologues in H. sapiens, Notch(1-4) (figure 1). Notch is a single pass 
transmembrane protein. The extracellular domain contains a variable number of EGF 
repeats, ranging from 13 in C. elegans GLP-1 to 36 in H. sapiens NOTCH1. There are 
three LNR (Lin-12/Notch Repeats) domains following the EGF repeats. At the C-
terminal end of the extracellular domain of Notch, there is the Notch heterodimerization 
domain, consisting of HD-N and HD-C domains. The intracellular domain contains a 
RAM domain followed by six ankyrin repeats, a transactivation domain and a PEST 
domain. The function of these domains will be discussed below. 
The Notch ligands are not as well conserved as Notch across species. They are 
more diverse in structure (reviewed in D'Souza et al. 2010). However, there are a few 
structural similarities among the canonical DSL ligands. They share an N-terminal (NT) 
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domain, followed by a DSL (Delta/Serrate/Lag-2) domain and multiple EGF-like 
domains (Tax et al. 1994). As with the Notch receptor, the number of EGF repeats are 
variable. The intracellular portion is very divergent and there are no recognizable 
conserved domains across different species. 
Notch signaling mechanism: 
 
Notch mediates cell-cell interactions during the development of metazoan 
organisms. These interactions occur between a cell, that sends the signal, the signal-
sending cell, and a cell, that receives the signal, the signal-receiving cell (see figure 2). 
The Notch receptor is present on the plasma membrane of the signal-receiving cell, while 
the DSL ligands are present on the plasma membrane of the signal-sending cell.  
In vertebrates, maturation of Notch receptors requires a proteolytic cleavage by 
the Furin protease at the extracellular domain (site 1 or S1) during the secretory pathway 
(Blaumueller et al. 1997; Logeat et al. 1998). As a result of this cleavage event, the 
vertebrate Notch is present at the cell surface as a heterodimer (Blaumueller et al. 1997; 
Logeat et al. 1998). However, in D. melanogaster the Furin-like enzymes and S1 
processing does not appear to be required for Notch function. Drosophila Notch is 
present at the plasma membrane as a full-length protein, and the predicted Furin 
processing site is dispensable for Notch activity (Kidd 2002). Although, the role for Furin 
processing in C. elegans GLP-1 and LIN-12 has not been characterized, there is evidence 
that suggests that S1 cleavage does take place. The C. elegans Notch receptor GLP-1 is 
not present predominately as a full-length protein product in wild-type animals, 
suggesting that it is processed (Crittenden et al. 1994). 
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Activation of the Notch receptor occurs when a DSL ligand binds to the EGF 
repeats on the extracellular domain of Notch. This binding triggers a series of proteolytic 
cleavage events. The first proteolytic event, at the site 2 or S2, occurs on the extracellular 
domain, and it is mediated by a conserved family of metalloproteases including SUP-
17/Kuzbanian and ADM-4/TACE (Wen et al. 1997; Brou et al. 2000; Jarriault & 
Greenwald 2005). This cleavage step is an important event in the Notch signal 
transduction cascade. The S2 site is normally concealed from the ADAM proteases by 
being buried within the Notch Negative Regulatory Region (NRR), which includes the 
LNRs and the heterodimerization domains (Sanchez-Irizarry et al. 2004; Gordon et al. 
2009). Binding of the DSL ligands to Notch exposes the S2 cleavage site to proteolytic 
cleavage by the ADAM proteases.  
Furthermore, mutations that disrupt the NRR can lead to ligand-independent 
activation of Notch. These active mutations have been isolated in C. elegans lin-12 and 
glp-1, as well as oncogenic mutations in human NOTCH1 present in patients with T-ALL 
(Greenwald & Seydoux 1990; Berry et al. 1997; Pepper et al. 2003; Weng et al. 2004). 
The second cleavage step occurs within the transmembrane domain of Notch, 
referred to as site 3 or S3, which releases the Notch intracellular domain from the 
membrane. The S3 cleavage is mediated by the presenilin containing γ-secretase complex 
(Levitan & Greenwald 1995; X. Li & Greenwald 1997; Yu et al. 2000; Struhl & 
Greenwald 1999; Struhl & Greenwald 2001; Francis et al. 2002). The remaining protein 
stub is cleared away from the membrane by the γ-secretase complex at the S4 cleavage 
site, through its ε-secretase activity (Okochi et al. 2002; Chandu et al. 2006). 
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The Notch intracellular domain (NICD) translocates to the nucleus and forms a 
tripartite complex with the sequence-specific DNA binding protein CBF1/Su(H)/LAG-1 
(CSL) and the co-activator SEL-8/MAM to activate transcription of target genes (Struhl 
et al. 1993; Christensen et al. 1996; Roehl et al. 1996; Wu et al. 2000; Petcherski & 
Kimble 2000). The trimeric complex CSL-NICD-MAM recruits co-activators such as 
histone acetyltransferases, chromatin remodeling factors and the mediator complex (Fryer 
et al. 2004; reviewed in Bray 2006). 
Notch signaling in C. elegans development: 
 
The glp-1 and lin-12 genes are involved in several cell fate decisions in C. 
elegans development. I will highlight a few of the well-studied cellular context where 
glp-1 and lin-12 are required for development in C. elegans. 
Germline development and Notch: 
 
The C. elegans adult gonad is composed of two U-shaped tubular structures 
emanating from the body midline, with one tube extending anteriorly and the other 
extending posteriorly. At the distal end of each tube resides a somatic gonadal cell, the 
distal tip cell (DTC). The distal germ cells undergo proliferative mitotic cell division to 
maintain its population (Kimble & White 1981). As the germ cells migrate away from the 
distal end, they enter meiosis and undergo oocyte differentiation (Kimble & White 1981). 
Surrounding the germline are auxiliary cells from the somatic gonad called the sheath 
cells (Kimble & Hirsh 1979; Hall et al. 1999).  
5
	  
The germline arises from the P lineage during embryogenesis; the descendants of 
this cell, Z2 and Z3, will give rise to the germline cells of the hermaphrodite. Germline 
specification requires the pie-1 gene and the mes genes for proper development (Mello et 
al. 1996). As the organism hatches from embryogenesis, the gonad primordium contains 
4 cells, Z1 through Z4 (Kimble & Hirsh 1979). Z1 and Z4 will develop into the somatic 
gonad (see below), while the Z2 and Z3 cells will generate the entire germline. From the 
L1 through the L4 stage of development, the germline proliferates exponentially 
undergoing several rounds of mitotic division. During the L3 stage, proximal germ cells 
enter meiosis and then proceed to differentiate into sperm cells at L4 stage. In the late L4, 
meiotic cells make a switch from sperm differentiation to oocyte formation (figure 3; 
(Lints & Hall 2009). 
The germline requires inputs from the somatic gonad for its development and 
maintenance. The distal tip cells are located at the distal end of either gonadal arm (figure 
3). Experiments where the distal tip cells, or its progenitors, are ablated show a reduction 
of proliferation of the germ line and the germ cells prematurely enter meiosis (Kimble & 
White 1981).  
Screens for mutants in germline proliferation recovered the Notch gene glp-1 
(Austin & Kimble 1987). glp-1 is required in the germ cells for initiation and 
maintenance of mitotic cells in the distal gonad (Austin & Kimble 1987; Austin et al. 
1989). Subsequent experiments showed that the DSL ligand lag-2 is expressed in the 
distal tip cell and signals to the germline to activate glp-1 (Lambie & Kimble 1991; 
Henderson et al. 1994).  
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In strong glp-1(gf) mutants, the germline fails to exit mitosis, thus fails to enter 
meiosis and therefore the hermaphrodites are sterile with a germline tumorous phenotype 
(Berry et al. 1997). In weak glp-1(gf) alleles, such as glp-1(ar202), a proximal tumor 
develops first and a late-onset tumor develops after the animals reach adulthood (Pepper 
et al. 2003).  
In the germline, FBF-2, an RNA binding protein, appears to be a direct target of 
GLP-1 (Lamont et al. 2004). FBF-2 along with FBF-1 control the extent of the distal 
mitotic region (Crittenden et al. 2002; Lamont et al. 2004). The activity of FBF-1 and 
FBF-2 is to inhibit the activities of GLD-1 and GLD-2 in the distal mitotic zone (Hansen 
et al. 2004). GLD-1 and GLD-2 functions in redundant pathways to promote meiotic 
progression (Francis et al. 1995; Kadyk & Kimble 1998; Hansen et al. 2004; Eckmann et 
al. 2004). GLD-1 is part of RNA binding complex with NOS-3, that negatively regulates 
translation of mRNAs involved in proliferation, including that of glp-1 (Marin & Evans 
2003). GLD-2, a poly(A) polymerase, is also involved in meiotic progression, it acts in 
part to promote GLD-1 translation (Kadyk & Kimble 1998; Wang et al. 2002; Suh et al. 
2006).  
It appears that the function of GLP-1 in the germline is to suppress the activities 
of GLD-1 and GLD-2 in the distal germline, thus preventing entry into meiosis (Kadyk & 
Kimble 1998). It is likely that glp-1 has other downstream targets, either directly or 
through the FBFs, which play a role in the maintenance of proliferation or inhibition of 
meiotic entry (see Hansen & Schedl 2006). 
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Embryogenesis and inductive signaling by Notch: 
 
There are many decisions during embryogenesis that are imparted by the Notch 
receptors glp-1 and lin-12 (Priess et al. 1987; Mello et al. 1994; Moskowitz & Rothman 
1996; Mickey et al. 1996; Neves & Priess 2005). The first such decision occurs at the 4-
cell stage of embryogenesis. The descendants of the AB cell express the Notch receptor 
glp-1 (Evans et al. 1994). The DSL ligand apx-1 is expressed in the P2 cell and signals to 
the glp-1 expressing ABp cell (Mello et al. 1994; Mango et al. 1994; Moskowitz et al. 
1994; Mickey et al. 1996). Activation of the Notch pathway in the ABp cell leads to the 
transcriptional activation of ref-1 in the ABp descendants (Neves & Priess 2005). 
Activation of ref-1 inhibits Notch activation in the ABp descendants during the second 
Notch decision (Neves & Priess 2005). Another outcome of the first Notch decision is 
that it establishes embryonic asymmetry, for example, the asymmetry between the 
gustatory neurons ASEL and ASER (Poole & Hobert 2006).  
The second Notch decision determines the cell fate of ABalp and ABara during 
the 12-cell stage (Hutter & Schnabel 1994; Mango et al. 1994). This fate is mediated by 
glp-1 in the receiving cell and an unknown ligand in the sending cell, though it is clear 
that the signal is coming from the MS cell (Hutter & Schnabel 1994). If the first Notch 
signal is inhibited, while the second signal is allowed, such as in an apx-1 mutant or by 
ablating the P2 cell, the ABp descendants are able to receive the glp-1 signal from the MS 
cell and lead them into an ABa-like lineage (Mango et al. 1994; Mickey et al. 1996). The 
outcome of loss of Notch signaling in the first Notch mediated decision is a production of 
an excess of pharyngeal cells (Mango et al. 1994).  
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The first two Notch decisions are mediated by the maternally provided glp-1 gene 
(Priess et al. 1987; Austin & Kimble 1987). The activation of glp-1 in these decisions 
leads to the transcription of the other C. elegans Notch receptor lin-12 in the embryo 
(Moskowitz & Rothman 1996). Together, glp-1 and lin-12 are involved in the third and 
fourth Notch mediated decisions during embryogenesis (Moskowitz & Rothman 1996).  
The third Notch mediated decision specifies the left side of the C. elegans head. 
Without Notch signaling at this step the head develops asymmetrically. The cell that 
contributes to the left head is the ABplaaa cell, while ABarpap cell contributes to the 
right head (Sulston et al. 1983). The Notch receptor lin-12 is expressed in the ABplaaa 
cell, and it is dependent on glp-1 activity in early embryogenesis (Moskowitz & Rothman 
1996). The DSL ligand lag-2 is expressed in neighboring cells and presumably signals to 
the ABplaaa cell, specifying the left head cell fate (Moskowitz & Rothman 1996). Loss 
of components of the Notch pathways such as the glp-1(lf) lin-12(lf) double mutant, lag-
1(lf) or lag-2(lf) single mutants have morphological defects that are associated with the 
loss left head specification (Moskowitz & Rothman 1996). 
The fourth Notch mediated decision specifies the excretory cell, which is absent 
in a lin-12 glp-1 double mutant (Lambie & Kimble 1991; Abdus-Saboor et al. 2011). 
There are other cell fate decisions mediated by Notch during embryogenesis, as observed 
in the various pleiotropies in glp-1 lin-12 double mutants which lead to the Lag 
phenotype (Lambie & Kimble 1991; Rasmussen et al. 2008).   
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The somatic gonad and lateral inhibition mediated by Notch: 
 
During the development of the hermaphrodite gonad, the anchor cell (AC) serves 
as a signaling center to coordinate cell fate specification and morphology of the 
developing vulva and uterus (Sternberg 2005; Sulston & White 1980; Kimble 1981). The 
AC and the rest of the somatic gonad are derived from the MS blastomere during 
embryogenesis (Sulston et al. 1983). After six rounds of divisions, the descendants of the 
MS blastomere, MSpppaap and MSappaap give rise to the Z1 and Z4 cells respectively 
(Sulston et al. 1983). These cells will contribute to the maintenance and development of 
the germline, as the distal tip cell and sheath cells are derived from Z1 and Z4 (see 
above). The remainder of the cells derived from Z1 and Z4 will contribute to the rest of 
the somatic gonad. 
In a rare case of lineage variance in C. elegans the AC fate is chosen by one of 
two equivalent cells, Z1.ppp and Z4.aaa. One cell will become the AC and the other cell 
will become a ventral uterine precursor cell (VU). In 50% of wild-type animals, Z1.aaa 
will become the AC and in the other 50% of wild-type animals, Z1.ppp will become the 
AC (Kimble & Hirsh 1979). The choice between the AC and the ventral uterine precursor 
(VU) is mediated by Notch signaling and it is termed the AC/VU decision (Greenwald et 
al. 1983; Seydoux & Greenwald 1989).  
The role of Notch in the AC/VU decision has been elucidated by a series of 
genetic experiments (Greenwald et al. 1983; Seydoux & Greenwald 1989; Wilkinson et 
al. 1994; Karp & Greenwald 2003). The default state of the pre-AC/pre-VU pair seems to 
be the AC fate, as in lin-12(0) or lag-2(lf) animals, there are two ACs and one less VU. In 
contrast, gain-of-function lin-12 alleles do not have an AC (Greenwald et al. 1983). Both 
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LIN-12 and LAG-2 are present in Z1.ppp and Z4.aaa prior to commitment. LIN-12 
activation by LAG-2 in the pre-VU cell increases or maintains lin-12 mRNA levels and 
down-regulates lag-2 transcription (Wilkinson et al. 1994). This creates a feedback 
mechanism, where the cell that has more LIN-12 activity is inhibited from adopting the 
AC fate. 
The role of LIN-12 signaling in the AC/VU is analogous to the role of Notch 
signaling in sense organ precursor (SOP) specification in D. melanogaster. In C. elegans 
the role hlh-2 plays in the AC/VU is similar to the orthologous hlh-2 genes in D. 
melanogaster and vertebrates, Daughterless and E2A respectively (reviewed in Tanigaki 
& Honjo 2010). The bHLH gene hlh-2 plays two roles in the AC/VU decision: one is to 
establish competence of pre-AC/pre-VU pair, and the other is to establish AC fate 
specification (Karp & Greenwald 2003; Karp & Greenwald 2004). These roles are very 
similar to the role of the pro-neural genes Acute-Scute/Daughterless in SOP specification 
(Heitzler & Simpson 1991; Heitzler et al. 1996). However, there is no evidence of a gene 
or genes performing the analogous role of the E(spl)-C/HES genes in the AC/VU 
decision, although in embryogenesis the ref-1 family of bHLH transcription factors seems 
to play an analogous role to the E(spl)-C/HES genes (Karp 2004; Neves & Priess 2005). 
Vulval precursor cells and Notch mediated cell-fate decision: 
	  
The C. elegans vulva arises from a group of ventral epidermal cells, the vulval 
precursor cells (VPCs). There are six cells, P3.p-P8.p, which are born in the L1 stage and 
are fated to become the VPCs (Sulston & Horvitz 1977). These are a group of equipotent 
cells that have the potential to give rise to the adult vulva (Sulston & White 1980). 
During the L2 stage, the proximal most VPC, the P3.p fuses with the hypodermal 
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syncytium, hyp7 in 50% of wild-type worms (Sulston & Horvitz 1977). It is during the 
L3 stage that the VPCs adopt distinct fates. The P6.p is instructed to adopt the 1° cell, 
while P5.p and P7.p adopt the 2° fate. P3.p, P4.p and P8.p adopt the 3° fate, which is a 
non-vulval fate (Sulston & White 1980; Sternberg & Horvitz 1986). The 3° cells divide 
once and fuse with hyp7. The 1° and 2° cells will give rise to the adult vulva.  
To establish and maintain VPC competence requires a set of transcription and 
signaling events (Clark et al. 1993; Eisenmann et al. 1998; Myers & Greenwald 2007). 
The Hox gene lin-39 is necessary for establishing and maintaining VPC identity (Clark et 
al. 1993; Maloof & Kenyon 1998). Both the WNT signaling pathways and the EGFR 
signaling pathway are required for maintaining VPC competence (Eisenmann et al. 1998; 
Myers & Greenwald 2007). Although, components of LIN-12 and EGFR signaling are 
present during the L2 stage, the VPCs do not adopt their fates until the L3 fates. The 
heterochronic genes lin-4, lin-14 and lin-28 play a role in the temporal control of VPC 
specification (Ambros & Horvitz 1984; Euling & Ambros 1996; J. Li & Greenwald 
2010). 
During the L3, coordination between two signaling pathways, the Notch and 
EGFR pathways, instruct the VPCs to adopt their fates (see Sternberg 2005). A signal 
emanating from the AC in the somatic gonad instructs P6.p to adopt a 1° fate. In the 
absence of an AC, the VPCs fail to receive the inductive signal and they adopt a 3° fate 
and fuse with hyp7 (Kimble 1981). The EGFR signaling pathway was found to be 
required for the P6.p cell specification and vulval induction (Horvitz & Sulston 1980; 
Sulston & Horvitz 1981; Ferguson & Horvitz 1985; Ferguson et al. 1987; Hill & 
Sternberg 1992). The EGF-like ligand lin-3 is expressed in the AC and signals to P6.p 
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(Hill & Sternberg 1992). Mutants in lin-3 and the EGFR let-23 show a defect in vulval 
induction (Vul) (Ferguson et al. 1987).  
A consequence of receiving EGFR signaling in P6.p is the transcriptional 
activation of the DSL ligands lag-2 and apx-1 (Chen & Greenwald 2004; Zhang & 
Greenwald 2011). P6.p sends a signal to both its neighbors, P5.p and P7.p, via Notch 
signaling to specify the 2° fate. In lin-12(lf) mutants, P5.p and P7.p fail to adopt the 2° 
fate, while in lin-12(gf) mutants all VPCs adopt 2° fate characteristics in the absence of 
the AC (Greenwald et al. 1983).  
There is extensive, mutual inhibitory regulation between EGFR signaling and 
LIN-12/Notch signaling in the presumptive VPCs. Not only does EGFR signaling 
activate the transcription of the DSL ligands in P6.p, but it also down-regulates LIN-12 
protein levels in P6.p (Levitan & Greenwald 1998; Shaye & Greenwald 2002; Shaye & 
Greenwald 2005). In addition, when a constitutive active form of LIN-12, either LIN-
12(ΔEΔDTS) or LIN-12(INTRA) is expressed in the VPCs, where the AC is present, the 
transcriptional activity of LIN-12 in P6.p is blocked by an unknown mechanism (Shaye 
& Greenwald 2002; J. Li & Greenwald 2010). 
The activation of lin-12 in 2° VPCs induces the expression of several genes called 
the lateral signal target (lst) genes (Yoo et al. 2004; Yoo & Greenwald 2005; Choi 2010). 
Many of these lst genes play a role in the down-regulation and attenuation of EGFR 
signaling (Berset et al. 2001; Yoo et al. 2004; Yoo & Greenwald 2005). The extensive 
feedback mechanisms between EGFR and LIN-12/Notch ensure robustness and precision 
in VPC specification. 
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Genetic approaches for Notch components: 
  
Genetic screens have been very successful at uncovering novel Notch 
components, in C. elegans and in Drosophila melanogaster. In C. elegans a number of 
screens were done that identified components of the Notch pathway. Some of these 
screens were done on the basis of phenotypes, such as the Glp, Lag and Lin screens. 
Although these resulted in the identification of a few members of the Notch pathway, 
specifically; glp-1, lin-12, lag-1 and lag-2 (Ferguson & Horvitz 1985; Austin & Kimble 
1987; Lambie & Kimble 1991). Suppression and enhancement screens have been more 
effective in identifying Notch pathway components in C. elegans. I will highlight some 
of the screens in search of mutations that suppress or enhance of lin-12 or glp-1 
associated phenotypes below. 
Suppressors and enhancers of lin-12 (sel): 
  
Several screens for suppressors and enhancers of lin-12 have been attempted to 
identify regulators of Notch signaling (Sundaram & Greenwald 1993; Levitan & 
Greenwald 1995; Tax et al. 1997; Katic et al. 2005). These screens have been immensely 
successful in identifying components of the Notch signaling pathway in C. elegans (see 
Greenwald 2005). Most of these screens attempted to suppress the egg-laying defective 
phenotype of lin-12(gf) alleles. I will not be discussing these in detail, although below I 




Enhancers of glp-1(lf) (ego): 
 
A screen for enhancers of a loss-of-function allele of glp-1 identified several 
potential Notch interactors (Qiao et al. 1995). The allele used in the screen was the 
temperature-sensitive mutant glp-1(bn18) at the non-permissive temperature, 25 °C, these 
mutants display a Glp phenotype. At 15 °C and 20 °C the glp-1(bn18) mutant has normal 
germ-line proliferation. The genes identified enhanced the loss-of-function phenotype of 
glp-1(bn18), such that the double mutants displayed a Glp phenotype at 20 °C. 
The screen recovered mutations in two previously identified genes, lag-1 and glp-
4. The gene lag-1 had been identified in a screen for the Lag phenotype, which is a Notch 
loss-of-function phenotype (Lambie & Kimble 1991). glp-4 originally was identified in a 
screen for under-proliferating germline and is a tRNA synthetase (Schedl, T; personal 
communication). The screen also identified five new ego genes. Out of the five ego genes 
only two have been cloned. EGO-1 is RNA-directed RNA polymerase, which is critical 
for RNAi in the germline (Smardon et al. 2000; Maine et al. 2005). It is likely that it is 
not involved in Notch signaling per se. 
The other cloned gene, ego-2 appears to be a bona-vide Notch interactor (Liu & 
Maine 2007). It enhances several loss-of-function phenotypes in the embryo, during 
larval development and during germline development. ego-2 functions in somatic tissue 
to promote glp-1 signaling in the germline, thus, it is likely that ego-2 functions to 
promote the ligand activity in the DTC (Liu & Maine 2007). EGO-2 is homologous to 
yeast Bro1p, which is involved in the endocytic pathway, specifically in the 
multivesicular endosome-sorting pathway.  
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The C. elegans Epsin orthologue, epn-1, is required for the function of the DTC 
ligand to promote glp-1 dependent germ-line proliferation (Tian et al. 2004). As Epsin is 
a component of the endocytic pathway, it is tempting to speculate that ego-2 and epn-1 
function in a similar pathway to promote ligand function. Interesting, the other Bro1p 
orthologue in C. elegans, ALX-1 has been implicated in the downregulation of the LIN-
12 in the primary VPC (Shaye & Greenwald 2005). ego-2 and alx-1 function 
antagonistically to each other in respect to certain Notch functions (Liu & Maine 2007). 
 
Suppressors of glp-1(lf) (sog): 
  
A screen for suppression of a loss-of-function allele of glp-1 identified several 
potential Notch interactors. There were two temperature-sensitive alleles used in the 
screen, glp-1(q224) and glp-1(q231) (Kodoyianni et al. 1992). These two mutations show 
a loss-of-function a Glp phenotype, at 20 °C and 25 °C and are viable and fertile at 15 °C. 
The genes identified suppress the loss-of-function phenotype of glp-1(q224) and/or glp-
1(q231), such that the double mutants were viable and fertile at 20 °C (Maine & Kimble 
1993). 
Six genes were identified to suppress the loss-of-function phenotypes of glp-1. 
These genes were identified as sog genes. All of the identified sog genes were able to 
suppress both the germline phenotype and the embryonic phenotypes associated with glp-
1(lf). However, the sog genes did not have phenotypes on their own and thus were not 
pursued any further (see Kimble & Crittenden 2005). 
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Tumorous enhancers of glp-1(gf) (teg): 
 
A screen for enhancers of a weak gain-of-function glp-1 mutant identified four teg 
genes. The screen was performed on a glp-1(oz112oz120) double mutant that has a weak 
over-proliferation of the germline phenotype (Berry et al. 1997). The mutants recovered 
in the screen enhanced tumorous phenotype of glp-1(oz112oz120), reminiscent of glp-
1(oz112) . Two of the four genes were mapped and cloned; teg-1 and teg-4 encode 
mRNA splicing factors. It appears that teg-4 is not involved in Notch signaling, but it is 
involved in meiotic entry of the germline (Mantina et al. 2009). 
γ-secretase complex in Notch transduction and APP 
processing: 
   
The γ-secretase complex contains a presenilin, SEL-12 or HOP-1, and includes 
other components as well: APH-1, a seven transmembrane domain protein; APH-2, a 
type I integral membrane protein thought to be the substrate receptor for γ-secretase; and 
PEN-2, a small protein with two transmembrane domains (Kimberly et al. 2003; Edbauer 
et al. 2003; reviewed in Jorissen & Strooper 2010). The presenilins provide the catalytic 
activity of the complex (Wolfe et al. 1999). It is thought that the presenilins are mainly 
involved in ectodomain shedding, as the γ-secretase complex only cleaves small 
extracellular stubs without sequence specificity (Struhl & Adachi 2000). It appears as 
though the γ-secretase complex has been co-opted by the Notch pathway as mutations in 
the presenilin catalytic subunits, sel-12 and hop-1, phenocopies loss of Notch signaling in 
C. elegans (X. Li & Greenwald 1997; Westlund et al. 1999). This is also true in mice and 
flies where the loss of the Presenilin subunit has phenotypes associated with loss of 
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Notch signaling in those organisms (Donoviel et al. 1999; Herreman et al. 1999; Struhl & 
Greenwald 1999; Ye et al. 1999). 
Genetic analysis identified many of the core components of the γ-secretase 
complex. In humans, the Presenilin locus was first identified in genetic linkage studies 
for Familial Alzheirmer’s Disease (FAD) families (Schellenberg et al. 1992; Van 
Broeckhoven et al. 1992; St George Hyslop et al. 1992; Sherrington et al. 1995). In C. 
elegans, a genetic screen for suppression of a gain-of-function lin-12 allele, the worm 
orthologue, sel-12 was identified as a Notch pathway component (Levitan & Greenwald 
1995). 
 Biochemical studies identified Nicastrin as a presenilin interactor in mammalian 
cell lines (Yu et al. 2000). Although a genetic locus which contains Nicastrin was 
identified in genetic linkage studies of FAD families, it is unclear whether 
polymorphisms in Nicastrin correlate with AD pathlogies (Zubenko et al. 1998; Kehoe et 
al. 1999; Orlacchio et al. 2002; Confaloni et al. 2003). In C. elegans, a screen for genes 
involved in the development of the anterior pharynx found APH-2, the C. elegans 
Nicastin orthologue (Goutte et al. 2000). The aph-2 gene was subsequently found to 
genetically interact with lin-12 in various cell fate decisions (Levitan et al. 2001).  
The other core components of the γ-secretase complex were identified in C. 
elegans using genetic analysis. In the same screen that identified aph-2, another γ-
secretase component APH-1 was uncovered (Goutte et al. 2002). In a screen for 
enhancement of a sel-12 loss-of-function mutation in C. elegans, yet another component 
of the γ-secretase was found, PEN-2 (Francis et al. 2002). APH-1 and PEN-2 were found 
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to be required for γ-secretase activity in conjunction with Presenilin and Nicastrin 
(Kimberly et al. 2003; Edbauer et al. 2003). 
Null mutations in the three auxiliary components of γ-secretase complex, aph-1, 
aph-2 and pen-2, display phenotypes which are associated with the loss of Notch 
signaling in C. elegans; mainly, they have a maternal-effect lethal (Mel) phenotype and a 
loss of the anterior pharynx (Aph) phenotype (Goutte et al. 2000; Levitan et al. 2001; 
Francis et al. 2002; Goutte et al. 2002). They also interact with components of the Notch 
pathway (Levitan et al. 2001; Francis et al. 2002). This suggests that in C. elegans the 
main function of the γ-secretase complex is to promote Notch signaling. Studies in mice 
also provide evidence that the components of the γ-secretase complex are mostly 
involved in promoting Notch signaling (Shen et al. 1997; Donoviel et al. 1999; Herreman 
et al. 2003; T. Li et al. 2003; Ma et al. 2005; Serneels et al. 2005). 
Although it appears that the main function of the γ-secretase complex is to 
promote Notch signaling, there have been other γ-secretase substrates identified 
(reviewed in Parks & Curtis 2007). The most important, medically and historically, is the 
protein APP, whose processing by γ-secretase complex leads to the accumulation of Aβ 
peptides, which are found in amyloid plaques of patients suffering from Alzheimer’s 
disease (Kang et al. 1987; Goate et al. 1991; Scheuner et al. 1996). Like Notch, the 
extracellular domain of APP undergoes two rounds of proteolytic cleavages; in neurons 
these cleavages of APP occur at the S2 site by the BACE protease and then at the S3 site 
by the γ-secretase complex (De Strooper et al. 1998; Vassar et al. 1999). Normally, the γ-
secretase complex generates a 40 amino acid peptide known as Aβ40 and also a minor 
larger peptide species, Aβ42. Mutations in PS1 found in some FAD patients cause a shift 
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in the processing of the extracellular domain of APP towards the production of the larger 
Aβ42 peptide; the two extra amino acids in the Aβ42 peptide cause a propensity of the Aβ 
peptides to aggregate; thought to be the cause of plaque formation and progression of 
Alzheimer’s disease (Scheuner et al. 1996). 
There has been an interest in the γ-secretase complex not only in its relation to 
Notch signaling but also APP processing. In an attempt to better understand the γ-
secretase complex, Wakabayashi et al. pulled down the γ-secretase complex and 
identified proteins that were associated with γ-secretase by mass-spectrophotometry 
(Wakabayashi et al. 2009). They were successful in identifying the tetraspanins CD81 
and CD9 as facilitating the γ-secretase ability to process the APP type I integral 
membrane protein. In a separate study, originating with genetic analysis of tetraspanins in 
C. elegans, the mammalian tetraspanins TSPAN33 and TSPAN5 were found to facilitate 
Notch signaling at the level of γ-secretase activity, while reduction in CD81 did not affect 
Notch processing (Dunn et al. 2010). This leads to an intriguing possibility that there 
might be accessory proteins that differentially promote the processing of γ-secretase 
substrates. 
Summary of Results: 
 
Here, I present my studies performed during my graduate career. In Chapter 2, I 
discuss the attempt to develop a transgenic system using the bacteriophage φC31 
integrase system. The introduction and discussion of transgenesis in C. elegans will be 
discussed in Chapter 2 itself. I show evidence that φC31 integrase functions in C. elegans 
somatic tissue. I have been able to use φC31 integrase to mediate single-copy insertion of 
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a transgenes in the C. elegans germline, however I have not been able to repeat that 
result. 
In Chapter 3, I use genetic analysis to test many genes that were reported to be 
associated with the γ-secretase complex in a mammalian tissue culture system 
(Wakabayashi et al. 2009) to assess whether they are modulators of Notch in C. elegans. I 
have identified several genes that suppress a glp-1(gf) allele and one gene that suppress a 
glp-1(lf) allele. I discuss why these genes are unlikely to be bona fide Notch interactors in 
Chapter 3 and the General Discussion.  
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Chapter 1: Figures and Tables. 
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Presenilin SEL-12 PSN PS1HOP-1 PS2
Nicastrin APH-2 NCT NCSTN
Presenilin Enhancer PEN-2 PEN-2 PSENEN








Deltex - DELTEX DELTEX(1-4)
Numb NUM-1* NUMB NUMBNUMBL
Sel-10/FBW-7 SEL-10 AGO FBW-7
ITCH/WWP WWP-1 Su-Dx ITCH
WWP1
WWP2
Mib - MIB(1-2) MIB(1-2)
Neuralized F10D7.5* NEUR NEURL1B
Sugar
modifications
Pofut C15C7.7* NEUROTIC POFUT1
Poglut - RUMI POGLUT1
Fringe








Casein Kinase II KIN-3* CKIIALPHA* CSNK2A(1-2)KIN-10* CKIIBETA* CSNK2B
Nemo-like Kinase LIT-1* NMO* NLK
CDK8 CDK-8* CDK8* CDK8
GSK3β GSK3* SSG GSK3AGSKT GSK3B
Table 1: Notch Pathway Core Components and Modulators of Activity
Core components and modulators of Notch signaling in C. elegans, D. melanogaster and H. 
sapiens. *Interactions of the genes marked with an asterisk in these organisms with the Notch 

































































































Figure 3: Germline development and proliferation maintenance:
A. Schematic of germline development. (Adapted from Lints and Hall, 2009)
B. Schematic of distal germline. The LAG-2 expressing DTC sends filopodia proximally in the 
germline. GLP-1 is expressed in the distal germline maintain those cells in a proliferate mitotic 
state. As GLP-1 activity decreases cells enter Meiosis.





















































Figure 4: Embryogenesis and Inductive Signaling:
At the 2-cell stage GLP-1 mRNA, which has been maternally loaded, is inhibited from transla-
tion by GLD-1. At the 4-cell stage GLP-1 is expressed in the AB daughters, ABa and ABp. As 
ABp is in contact with the signal sending P2 cell, GLP-1 becomes active in the ABp. At the 12-
cell stage, the GLP-1 transcriptional target, REF-1 is expressed in the ABp granddaughters. ABp 
descendants, in grey, are refractive to the signal from the MS cell. The second Notch inductive 
signal occurs between the MS cell and ABa descendants. At this stage, GLP-1 becomes active in 




























Figure 5: AC specification and lateral inhibition.
A)  Schematic of the lineage of the somatic gonad. The gonad primordium at the L1 stage and at 
the L2 molt. This is showing 5L configuration, where Z4.aaa has become the AC (anchor cell). 
DTC: distal tip cell. SS: spermatheca/sheath cell. DU: dorsal uterine. VU: ventral uterine (adapt-
ed from Lints and Hall 2009).
B) The AC/VU decision. At the L1 molt/early L2, LIN-12 is expressed in the daughters of Z1.pp 
and Z4.aa. LAG-2 is expressed in the Z1.ppp and Z4.aaa. During the decision, the Pre-AC cell 
downregulates LIN-12 levels, while the Pre-VU cell downregulates LAG-2 levels. Downregula-
tion of LIN-12 allows HLH-2 protein expression (adapted from Levitan and Greenwald 1998; 














Figure 6: VPC fate specification and LIN-12.
LIN-12 expression in the VPCs is visible during the L2 stage. During vulval induction of the 
VPCs, LIN-12 is down-regulated in P6.p, while the DSL ligands, LAG-2 and APX-1 are tran-
scribed in this cell. Expression of LIN-12 is maintained in the P5.p and P6.p daughter and the 
two inner most granddaughters (Levitan and Greenwald 1998). LIN-12 activity as monitored by 
2° cell markers are on in the same cell which have LIN-12 protein expression. After induction 
P3.p, P4.p and P8.p divide and fuse with hyp7 syncetium (adapted from Levitan and Greenwald 
1998).
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The ability to make transgenic animals has been a great tool for biologists to study 
living organisms. It has allowed scientists to uncover many aspects of biology: genetics, 
biochemistry, cell biology and neurobiology. In C. elegans, transgenes are generated by 
germline injections of DNA, which forms extra-chromosomal arrays that are composed 
of many copies of the injected DNA. The nature of extrachromosomal arrays makes them 
problematic in many circumstances. Furthermore, there is no single, simple, reliable 
approach that circumvents all of the problems with extrachromosomal arrays. I describe 
an attempt to use the φC31 integrase system, which has been used successfully in D. 
melanogaster for single copy insertion of transgenes into the genome. The bacteriophage 
φC31 integrase mediates sequence-specific recombination between two largely different 
sequences, called attB and attP. This method requires one of the att sites to be integrated 
into the genome. The work in this chapter deals with the attempts to adapt the φC31 
system for suitable use in C. elegans.  
Introduction: 
	  
The ability of making transgenes, that is the introduction of foreign DNA into an 
organism has been a very significant technical advancement which has helped modern 
biologist to better study living organisms and the processes involved therein. They have 
been instrumental in uncovering gene function at the cellular and tissue level of multiple 
biological model systems.  
31
	  
In C. elegans, the method for the introduction of transgenes was first attempted 
over 20 years ago (Stinchcomb et al. 1985). Due to the nature of C. elegans biology, 
injected foreign DNA undergoes concatemerization, recombination and non-homologous 
end-joining to form a pseudo-chromosome, called an extrachromosomal array 
(Stinchcomb et al. 1985). Such arrays contain multiple copies of the injected DNA, 
anywhere between 80-300 copies (Stinchcomb et al. 1985; Fire & Waterston 1989; Mello 
et al. 1991). Recent work has quantified the number of copies in several different arrays, 
which suggests transgenes are incorporated into arrays at a much lower copy number than 
previously thought (Cochella et al., personal communications, August 2011). The 
frequency of propagation of extrachromosomal arrays are quite variable, such that the 
array can be lost in cells or tissues creating mosaic animals or lost from the germline, 
making propagation of the array problematic (Mello & Fire 1995).  
Although extrachromosomal arrays have been very useful in studying gene 
function in C. elegans, there are many disadvantages to this technique. As there are many 
copies of the transgene, the levels of expression can be several fold higher than the 
original locus, which could complicate the interpretation of results obtained from 
extrachromosomal arrays (Fire & Waterston 1989).  
As extrachromosomal arrays are repetitive they trigger a silencing mechanism via 
RNAi. The germline in particularly is sensitive to array silencing (Kelly et al. 1997; Kelly 
& Fire 1998; Seydoux & Strome 1999). This makes it difficult to study gene expression 
and function in the germline. 
Techniques have been developed to overcome some of the limitation of 
extrachromosomal arrays. To overcome the propensity of extrachromosomal arrays to 
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silence, a method was developed to make the extrachromosomal array similar to 
chromosomes, by mixing digested genomic DNA with transgenes prior to injection 
(Kelly et al. 1997). Fosmid recombineering has been used to create reporter genes with 
higher expression fidelity as more of the genomic context is included in the transgene 
(Tursun et al. 2009). An added benefit is that the transgene itself is larger, thus arrays 
made from fosmids have lower copy number of the transgene (Tursun et al. 2009). To 
ensure that the transgenes segregate in a mendelian fashion, irradiating 
extrachromosomal arrays with γ-rays can integrate arrays into the genome (Mello & Fire 
1995). 
Two techniques have been used to integrate transgenes in low-copy number into 
the genome. Injection of DNA coding the sup-7(st5) mutant gene into the C. elegans 
germline inhibits extrachromosomal array formation due to the toxic effects of sup-7(st5) 
on gene translation, however at a low frequency the injected DNA can integrate into the 
genome at low-copy number (Fire 1986). The limiting aspect of this technique is the low 
frequency of the desired events. Another method to achieve low-copy integration of 
transgenes has been developed by introducing DNA via micro-particle bombardment 
(Praitis et al. 2001).  
The best approach for introducing transgenes into the C. elegans genome would 
have the ability to insert a transgene in single-copy at a known location. This would have 
many advantages over current methods of making transgenes. Recently, an approach has 
been developed that uses homologous recombination to introduce transgenes in single-
copy at a known location (Frøkjaer-Jensen et al. 2008). This method will be further 
elaborated in the results and discussion section. Site-specific recombination systems are 
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attractive tools, capable of providing specificity and ease-of-use, to introduce transgenes 
into the C. elegans genome.  
Site-specific recombination systems have been used very successfully in biology. 
Two recombination systems that mediate recombination between identical sequences 
have been developed for in-vivo use in model organisms. These are the Flp 
recombinase/FRT binding site from the yeast S. cerevisiae and the Cre recombinase/LoxP 
landing site from the bacteriophage P1 (Golic & Lindquist 1989; Golic 1991; Sauer & 
Henderson 1988). Flp/FRT systems have been successful in D. melanogaster to generate 
involves flanking a gene of interest by a pair of FRT sequences in tandem. Expressing the 
Flp recombinase using a heat-shock promoter, causes the gene of interest to be excised 
from cells at random, thus creating mosaic animals (Golic & Lindquist 1989). A variation 
of this method has been used to induce gene expression, where the excision of the 
intervening sequence would cause expression of a gene of interest (Struhl & Basler 
1993). Recently, the Flp/FRT system has been adapted for use in C. elegans (Voutev & 
Hubbard 2008; M. W. Davis et al. 2008; Vázquez-Manrique et al. 2010). The Cre/loxP 
system has been used in mammalian model organisms and mammalian cell lines in a 
similar way to the Flp/FRT site-specific recombination system (Sauer & Henderson 
1989; Sauer & Henderson 1988; Sauer & Henderson 1989; Orban et al. 1992; Gu et al. 
1993). As both of the recombinases, Flp and Cre, are bi-directional, they are an 
unattractive option to attempt recombinase mediated transgene insertion. 
The λ integrase, from the λ phage, is one of the best-studied site-specific 
integrases. It is required for the integration and excision of the λ prophage from the E. 
coli bacterial genome (reviewed in Van Duyne 2005). It mediates recombination between 
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an attB site in the prophage and an attP site in the E. coli genome creating two 
recombination products; attL and attR sites. The λ integrase requires an integration host 
factor (IHF) to be able to catalyze the integration event (Van Duyne 2005). For the 
excision event, λ integrase requires the IHF as well as another host factor, Fis, and the 
phage-produced factor Xis (Van Duyne 2005). The Xis factor stimulates the excision 
event as well as inhibits the integration event. Due to requirement of accessory factors, λ 
integrase has not been adapted for use in in-vivo systems, although, Invitrogen™ has 
commercialized it for in-vitro use under the brand Gateway®.  
The φC31 integrase is a member of a family of serine recombinases (Thorpe & 
Smith 1998; Thorpe et al. 2000). It is derived from the Streptomyces phage φC31, where 
it is required for the integration and excision of the φC31 phage genome into its host 
genome, in a similar fashion to λ integrase. During integration, φC31 integrase catalyzes 
recombination between attP and attB sites to create attR and attL sites (figure 2A). The 
attachment sites for φC31 are relatively small, less than 50 bp in length (Smith & Thorpe 
2002). The major difference between λ integrase and φC31 integrase, in terms of its 
ability to be used in heterologous recombination systems, is that φC31 integrase does not 
require accessory proteins to catalyze the recombination reaction between attB and attP 
sites (Thorpe et al. 2000). Recently, a phage produced factor from φC31 was found to 
change the directionality of φC31 integrase, that is to make φC31 integrase capable of 
mediating recombination between attL and attR sites (Khaleel et al. 2011). 
φC31 integrase has been used in many different organisms, including mammalian 
cell lines and has been a powerful molecular tool in D. melanogaster (Groth et al. 2000; 
Groth et al. 2004; Bischof et al. 2007). In either case, whether a cell line or a D. 
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melanogaster strain, attP sites were integrated into the genome. Expression of the φC31 
integrase along with the introduction of a donor plasmid, containing the attB site, is 
capable of placing the entire donor plasmid into the genome (see figure 2C). To 
differentiate the mechanism of integration by this method, I will refer to this as Whole 
Plasmid Integration or WPI. In Drosophila melanogaster, co-injection of φC31 mRNA 
and the donor plasmid into an attP containing strain result in successful integration of the 
donor plasmid, although the efficiency of mRNA based integration is very low (Groth et 
al. 2004; Bateman et al. 2006; Bischof et al. 2007; Bateman & Wu 2008). The issue of 
handling φC31 mRNA is a concern in terms of getting good integration efficiency. To 
bypass the requirement for co-injecting φC31 mRNA, transgenic animals expressing 
φC31 in the D. melanogaster germline were produced (Bischof et al. 2007). By injecting 
the donor plasmid into an attP line expressing φC31, the efficiency of integration was 
greatly increased (Bischof et al. 2007; Bateman & Wu 2008). The rate of integration 
approached 60% for some attP sites (Bischof et al. 2007). 
As an alternative to the WPI, another method has been developed (Bateman et al. 
2006). This method termed Recombination-Mediated Cassette Exchange (RMCE), uses 
two attP sites flanking a marker integrated into the genome. The donor plasmid contains 
two attB sites flanked by a transgene of interest. Injection of the donor plasmid plus a 
φC31 source should cause an exchange between the marker and the gene of interest (see 
figure 2D). By using a transgenic source of φC31, the integration frequency of RMCE 
was not significantly decreased from WPI (Bateman & Wu 2008). 
RMCE has several advantages to WPI. One advantage is that no vector sequence 
will be integrated with your transgene. In some cases, it might be undesirable to have 
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vector sequences in close proximity to your transgene. In C. elegans in particular, it has 
been shown that vector sequences can have an impact with the expression of transgenes 
in extrachromosomal arrays (Etchberger & Hobert 2008). With RMCE, the vector will 
not be integrated, eliminating one possible source of variability. Another advantage is 
that one can use the marker in the landing site as a negative selectable marker. In this 
way, one can distinguish between the integration at the landing site or between a pseudo 
attP site that might be present in the genome. It will be especially useful in C. elegans 
where there is a propensity for injected DNA to form extrachromosomal arrays. 
In this chapter, I show that φC31-mediated recombination works in C. elegans. I 
show that it can occur in somatic tissue, however it is difficult to determine how well it 
works in the germline. Getting high efficiency integration in the germline has proved 
elusive. In this chapter, I outline the methods tried for getting germline φC31 mediated 
integration. 




Caenorhabditis elegans var. Bristol strain N2 was the wild-type parent strain of 
all mutants and markers used. Key strains used herein were: 
HT1593: unc-119(ed3) 
GG48: emb-27(g48) 
GS5652: ttTi5605; unc-119(ed3) 
GS5653: unc-119(ed3); cxTi10882 
GS5654: unc-119(ed3); cxTi9393 
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GS5655: cxTi10471; unc-119(ed3) 
GS5780: emb-27(g48); ttTi9626 
GS5781: emb-27(g48); ttTi11418 
GS5694: emb-27(g48); arEx1323[Pceh-22::GFP:: unc-54 3’ UTR; Pglh-
2::3xHAφC31::glh-2 3’ UTR; emb-27(+)] 
GS5695: emb-27(g48); arEx1324[Pceh-22::GFP:: unc-54 3’ UTR; Pglh-
2::3xHAφC31::glh-2 3’ UTR; emb-27(+)] 
GS5595: arSi1[attP::Pglt-3::Venus::unc-54 3’ UTR::Cb unc-119(+)::sup-
7(st5)::attP]/ttTi5605; unc-119(ed3) 
GS5596: arSi1[attP::Pglt-3::Venus::unc-54 3’ UTR::Cb unc-119(+)::sup-
7(st5)::attP]/mnC1[dpy-10(e128) unc-52(e444)]; unc-119(ed3) 
GS5883: unc-119(ed3); arSi2[attP::Pglt-3::Venus::unc-54 3’ UTR::Cb unc-
119(+)::sup-7(st5)::attP]/cxTi10882 
GS5884: unc-119(ed3); arSi2[attP::Pglt-3::Venus::unc-54 3’ UTR::Cb unc-
119(+)::sup-7(st5)::attP]/mDf9 
GS6093: emb-27(g48); arSi3[emb-27(+)::Pglh-2::3xHAφC31::glh-2 3’ UTR] 
GS6094: unc-119(ed3) arSi3[emb-27(+)::Pglh-2::3xHAφC31::glh-2 3’ UTR] 
GS6095: arSi1[attP::Pglt-3::Venus::unc-54 3’ UTR::Cb unc-119(+)::sup-
7(st5)::attP]//mnC1[dpy-10(e128) unc-52(e444)]; arSi3[emb-27(+)::Pglh-
2::3xHAφC31::glh-2 3’ UTR] unc-119(ed3) 
GS6096: arSi3[emb-27(+)::Pglh-2::3xHAφC31::glh-2 3’ UTR] unc-119(ed3); 
arSi2[attP::Pglt-3::Venus::unc-54 3’ UTR::Cb unc-119(+)::sup-7(st5)::attP]//mDf9. 




MV83.3 and MV83.10: pha-1(e2123); arExMV83.3 or arExMV83.10[Phsp-
16.2::φC31::tbb-2 3’ UTR, Prpl-28::attP::pat-3::CFP::unc-54 3’ 




pMLV011: Homology region to ttTi5605: A 2.9 kb region flanking both sides of 
ttTi5605 Mos1 transposable element was amplified from N2 genomic DNA using primers 
ttTi5605-F (tcgagcaaatcgacaactttcca) and ttTi5605-R (cacggcgatatgtatctgtagatca) and 
AccuPrime pfx polymerase (Invitrogen) and cloned into pCR-BLUNT-II-TOPO 
(Invitrogen) to create pMLV010. An AscI restriction site was introduced in pMLV010 at 
the site of the mosI transposable element using primers QCttTi5605-top 
(ggtagcaaactcacttcgtgggcgcgccagtgcaagtaagatcagtgt) and QCttTi5605-bottom 
(acactgatcttacttgcactggcgcgcccacgaagtgagtttgctacc) and the QuikChange II XL site-
directed mutagenesis kit (Agilent Technologies). 
pMLV018: Homology region to cxTi10471: A 3.8 kb region flanking both sides 
of cxTi10471 Mos1 transposable element was amplified from N2 genomic DNA using 
primers cxTi10471-F (catcaaaaccatctgcaaatgc) and cxTi10471-R 
(gtgtgcagaacatccaaactagaa) and AccuPrime pfx polymerase (Invitrogen) and cloned into 
pCR-BLUNT-II-TOPO (Invitrogen) to create pMLV017. An AscI restriction site was 
introduced in pMLV017 at the site of the mosI transposable element using primers 
QCcxTi10471-F (gatgatgaagaatttggcgcgccatacaccagtttcgg) and QCcxTi10471-R 
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(ccgaaactggtgtatggcgcgccaaattcttcatcatc) and the QuikChange II XL site-directed 
mutagenesis kit (Agilent Technologies). 
pMLV059: Homology region to cxTi10882: A 4.2 kb region flanking both sides 
of cxTi10882 Mos1 transposable element was amplified from N2 genomic DNA using 
primers cxTi10882-F (tttgagcacttctgtcctacaagcc) and cxTi10882-R 
(gcatagcctgcaggattccatatt) and AccuPrime pfx polymerase (Invitrogen) and cloned into 
pCR-BLUNT-II-TOPO (Invitrogen) to create pMLV058. An AscI restriction site was 
introduced in pMLV058 at the site of the mosI transposable element using primers 
QCcxTi10882-F (gtacgagttctgcgtttttgaattggcgcgccatagaatcaagcatgctc) and QCcxTi10882-
R (gagcatgcttgattctatggcgcgccaattcaaaaacgcagaactcgtac) and the QuikChange II XL site-
directed mutagenesis kit (Agilent Technologies). 
pMLV063: Homology region to ttTi11418: A 4.8 kb region flanking both sides of 
ttTi11418 Mos1 transposable element was amplified from N2 genomic DNA using 
primers ttTi11418-F (cagcacagtcaatggagaaagca) and ttTi11418-R (taccccgcgacatttgaaaa) 
and AccuPrime pfx polymerase (Invitrogen) and cloned into pCR-XL-TOPO (Invitrogen) 
to create pMLV062. An AscI restriction site was introduced in pMLV062 at the site of 
the mosI transposable element using primers QC ttTi11418-F 
(tcactgttccaaaagttccttctaattggcgcgccatacccatcatgccg) and QC ttTi11418-R 
(cggcatgatgggtatggcgcgccaattagaaggaacttttggaacagtga) and the QuikChange II XL site-
directed mutagenesis kit (Agilent Technologies). 
pMLV105: Homology region to cxTi9393: A 5.0 kb region flanking both sides of 
cxTi9393 Mos1 transposable element was amplified from N2 genomic DNA using 
primers cxTi9393-F (ataacgtttcagataagcccaagg) and cxTi9393-R (tgcttgttgctgactgatcc) 
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and AccuPrime pfx polymerase(Invitrogen) and cloned into pCR-BLUNT-II-TOPO 
(Invitrogen) to create pMLV104. An AscI restriction site was introduced in pMLV104 at 
the site of the mosI transposable element using primers QCcxTi9393-F 
(cagtgagagcacagcgttggcgcgccaaattagcctaggggaaa) and QCcxTi9393-R 
(tttcccctaggctaatttggcgcgccaacgctgtgctctcactg) and the QuikChange II XL site-directed 
mutagenesis kit (Agilent Technologies). 
pMLV127: Homology region to ttTi9626: A 3.0 kb region flanking both sides of 
ttTi9626 Mos1 transposable element was amplified from N2 genomic DNA using primers 
ttTi9626-F (ggcaaaaacgtgagaaagagaag) and ttTi9626-R (gaaagccaaatgagaatcccg) and 




pMLV089: attP::Pglt-3::venus::unc-54 3’ UTR::Cb unc-119(+)::sup-
7(st5)::attP:  
attP site was amplified from pM(3xP3RFP-attP') (Bischof et al. 2007) using 
primers SAattP-F (atgagctcggcgcgccgtactgacggacacaccgaag) and NattP-R 
(tgctagctgtcggtcgactacaggtcactaat) then digested with SacI and NheI restriction enzymes 
and ligated to pBS II KS(-) (Agilent Technologies) digested with SacI and XbaI and 
treated with alkaline phosphatase to create pMLV006.  
A 1.0 kb region flanking sup-7 tRNA was amplified from N2 genomic DNA 
using primers Hsup-7-F (ataagcttccatgatgcgaaaatgacca) and Sup-7-R 
(tgttcagtttgcgggtgcat) and the Expand Long PCR kit (Roche) and cloned into pCR-XL-
TOPO(Invitrogen) to create pMLV027. A C to T change was introduced at the anti-codon 
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site to mimic the sup-7(st5) mutation with primers QCsup7(st5)-top 
(gtagcgcgttcgactctagatcgaaaggttgg) and QCsup7(st5)-bottom 
(ccaacctttcgatctagagtcgaacgcgctac) and the QuickChange II mutagenesis kit (Agilent 
Technologies) to create pMLV028. pMLV028 was digested with HindIII and NheI to 
liberate the 1.1 kb sup-7(st5) fragment and then it was cloned into the HindIII/SpeI sites 
of pMLV006 to create pMLV029.  
attP site was amplified from pM(3xP3RFP-attP') ((Bischof et al. 2007)) using 
primers KAattP-F (atggtaccggcgcgccgtactgacggacacaccgaag) and SattP-R 
(ccgagtcgacttcgcgctcgcgcgactgacgg) the Expand Long PCR kit (Roche), then digested 
with KpnI and SalI restriction enzymes and ligated to the KpnI/XhoI sites of pMLV029 
to create pMLV030. 
pDS263 (D. Shaye, unpublished) was digested with SphI to liberate a 4.2 Kb 
fragment containing Pglt-3::Venus::unc-54 3’UTR::Cbunc-119(+). This fragment was 
cloned into the EcoRV site of pMLV030 to create pMLV089. 
pMLV093: pMLV089 was digested with AscI to liberate the 5.7 Kb attP cassette. 
This fragment was inserted into the AscI site of pMLV011. 
pMLV098: pMLV089 was digested with AscI to liberate the 5.7 Kb attP cassette. 
This fragment was inserted into the AscI site of pMLV018. 
pMLV099: pMLV089 was digested with AscI to liberate the 5.7 Kb attP cassette. 
This fragment was inserted into the AscI site of pMLV059. 
pMLV115: pMLV089 was digested with AscI to liberate the 5.7 Kb attP cassette. 





pMLV025: attB::GatewayR1-R2::attB: Two oligos SAattBS-top 
(tggcgcgcctgacggtctcgaagccgcggtgcgggtgccagggcgtgcccttgggctccccgggcgcgtactccacctcac
cccatctggtccacgc) and SAattBS-bottom 
(gtggaccagatggggtgggatggagtacgcgcccggggagcccaagggcacgccctggcacccgcaccgcggcttcgag
accgtcaggcgcgccaagct) were annealed and kinase treated and inserted into the SacI/SacII 
sites of pBS II KS (-) (Agilent Technologies) to generate pMLV013. The R1-R2 gateway 
cassette fragment (Invitrogen) was cloned into the EcoRV site of pMLV013 to generate 
pMLV023. Finally, oligonucleotides KAattBA-top 
(ggcgcgcctgacggtctcgaagccgcggtgcgggtgccagggcgtgcccttgggctccccgggcgcgtactccacctcacc
ccatctggtccaaggcc) and KAattBA-bottom 
(ttggaccagatggggtgggatggagtacgcgcccggggagcccaagggcacgccctggcacccgcaccgcggcttcgag
accgtcaggcgcgccgtac) were annealed and kinase treated and inserted into the KpnI/ApaI 
site of pMLV023. 
pMLV026: attB::GatewayR3-R4::attB: R3-R4 Gateway cassette was amplified 
from pDEST(R3-R4) (Invitrogen) using primers oMV0003 
(caggatatccaactttgtatagaaaagtt) and oMV0004 (tacgatatccaactatgtataataaagtt) and 
AccuPrime pfx polymerase (Invitrogen), then digested with EcoRV and cloned into the 
EcoRV site of pMLV013 (described above) to create pMLV024. Finally, 
oligonucleotides KAattBA-top and KAattBA-bottom were annealed and kinase treated 
and inserted into the KpnI/ApaI site of pMLV024. 
pMLV077: attB::MCS::attB: A dual selection cassette containing the 
chloramphinocol resistance gene and ccdB death gene was amplified from pENTR4 
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(Invitrogen) using primers oMV0005 (caggatatccattaggcaccccaggcttt) and oMV0006 
(tacgatatcactggctgtgtataagggagcc) and AccuPrime pfx polymerase (Invitrogen), then 
digested with EcoRV and cloned into the EcoRV site of pMLV013 (described above) to 
create pMLV076. Finally, oligonucleotides KAattBA-top and KAattBA-bottom were 
annealed and kinase treated and inserted into the KpnI/ApaI site of pMLV077. 
pMLV085: attB::Pmyo-3::mCherry::unc-54 3’ UTR::attB: Plasmids pMLV082 
(described below), pMLV067 (described below), pCM1.35 (Seydoux & Dunn 1997) and 
pMLV026 (described above) were incubated with LR clonase II mix to allow for gateway 
recombination reaction as per manufacturers instructions (Invitrogen). 
attP/attB cassette: 
 
pMLV194: Prpl-28::attP::pat-3::CFP::unc-54 3’ UTR::attB::2xNLS::YFP::let-
858 3’ UTR: 2xNLS::YFP AgeI/EcoRI from p625 replaced 4xNLS::GFP from L4455 
from the Fire Vector kit with the rpl-28 promoter and let-858 3’ UTR creating pMLV191. 
Primers X-F(sequence) and X-R(sequence) containing the attP and attB sites were used 
to amplify pat-3::CFP::unc-54 3’ UTR from Fire Vector L4664 and cloned into pCR-
XL-TOPO vector via TOPO cloning (Invitrogen) to generate pMLV190. A BamHI digest 
liberated the 2.2 Kb attP::pat-3::CFP::unc-54 3’UTR::attB fragment and it was cloned 
into the BamHI site of pMLV191. 
φC31 vectors: 
 
pMLV022: pcDNA3.1_phiC31NLS: Primers QC-phiC31-AgeI-TOP 
(agacgtagcggcgaccggttagcgagacaccc) and QC-phiC31-AgeI-BOTTOM 
(gggtgtctcgctaaccggtcgccgctacgtct) were used to perform site-directed mutagenesis on 
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pcDNA3.1_phiC31 (Bischof et al. 2007) to introduce an AgeI site in the c-terminal 
portion of phiC31 to form pMLV019. Oligonucleotides phiC31-AgeINLS-TOP 
(ccgggccaaagaagaagcgtaaggtaggtacctaggctag) and phiC31-AgeINLS-BOTTOM 
(ccggctagcctaggtacctaccttacgcttcttctttggc) containing one NLS sequence were annealed 
and double-stranded oligonucleotides were treated with T4 polynucleotide kinase and 
ligated to AgeI site of pMLV019. 
pMLV074: pENTR[φC31]: Primers oC31B1-F 
(ggggacaagtttgtacaaaaaagcaggcttaaccggtagaaaaaatggacacgtacgcgggt) and oC31B2-2-R 
(ggggaccactttgtacaagaaagctgggtagctagcctacgccgctacgtcttc) with gateway sites were used 
to amplify φC31 from pcDNA3.1_phiC31 (Bischof et al. 2007) and cloned into 
pDONR221 via gateway cloning (Invitrogen). 
pMLV075: pENTR[φC31::NLS]: Primers oC31B1-F 
(ggggacaagtttgtacaaaaaagcaggcttaaccggtagaaaaaatggacacgtacgcgggt) and oC31-B2-R 
(ggggaccactttgtacaagaaagctgggtaggcgcgatccgggtgtct) with gateway sites were used to 
amplify φC31::NLS from pMLV022 and cloned into pDONR221 via gateway cloning 
(Invitrogen). 
pMLV090: pENTR[φC31w/ introns]: Artificial introns å and ∂ from the GFP fire 
vector kit (A. Fire, G. Seydoux, J. Ahnn and S. Xu, unpublished) were placed in the 
φC31 ORF. Annealed Intron-å-top(gtaagtttaaacatatatatactaactaaccctgattatttaaattttcag) and 
Intron-å-bot (ctgaaaatttaaataatcagggttagttagtatatatatgtttaaacttac) and treated double-
stranded oligo-nucleotide with T4 polynucleotide kinase, then ligated pMLV074 digested 
with FspI and dsIntron-å. Then, annealed Intron-∂-top 
(gtaagtttaaacatgattttactaactaactaatctgatttaaattttcag) and Intron-∂-bot 
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(ctgaaaatttaaatcagattagttagttagtaaaatcatgtttaaacttac) and treated double-stranded 
oligonucleotide with T4 polynucleotide kinase, then ligated pMLV074w/å digested with 
XmnI and dsIntron-∂. 
pMLV091: pENTR[φC31NLSw/ introns]: Artificial introns å and ∂ from the GFP 
fire vector kit (A. Fire, G. Seydoux, J. Ahnn and S. Xu, unpublished) were placed in the 
φC31 ORF. Annealed Intron-å-top(gtaagtttaaacatatatatactaactaaccctgattatttaaattttcag) and 
Intron-å-bot (ctgaaaatttaaataatcagggttagttagtatatatatgtttaaacttac) and treated double-
stranded oligo-nucleotide with T4 polynucleotide kinase, then ligated pMLV075 digested 
with FspI and dsIntron-å. Then, annealed Intron-∂-top 
(gtaagtttaaacatgattttactaactaactaatctgatttaaattttcag) and Intron-∂-bot 
(ctgaaaatttaaatcagattagttagttagtaaaatcatgtttaaacttac) and treated double-stranded 
oligonucleotide with T4 polynucleotide kinase, then ligated pMLV075w/å digested with 
XmnI and dsIntron-∂. 
pMLV110: pENTR[3xHAφC31]:  
pMLV111: pENTR[3xHAφC31NLS]: 
pMLV112: pENTR[3xHAφC31w/introns]: 
 pMLV113: pENTR[3xHAφC31NLSw/introns]: Annealed 3xHA-top 
(ccggtagaaaaaatgatctacccatacgatgttcctgactatgcgggctatccctatgacgtcccggactatgcagggtatccat
atgacgttccagattacgctgcg) and 3xHA-bot 
(ccggcgcagcgtaatctggaacgtcatatggataccctgcatagtccgggacgtcatagggatagcccgcatagtcaggaac
atcgtatgggtagatcattttttcta) and treated double-stranded oligonucleotide with T4 
polynucleotide kinase. Then ligated pMLV074, pMLV075, pMLV090 and pMLV091 
digested with AgeI and ds3xHA. 
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φC31 mosSCI plasmids: 
 
pMLV124: Pglh-2::3xHAφC31w/introns::glh-2 3’ UTR: Digested pJL43.1 with 
MluI, treated cut vector with Klenow fragment to generate a blunt-ends, then digested 
with NheI and treated cut vector with Alkaline phosphatase. Isolated 6 kb fragment. 
Digested pMLV112 with AgeI, treated cut vector with Klenow fragment to generate a 
blunt-end, then digested with NheI to isolate 1.9 Kb fragement. Inserted the 1.9 kb 
3xHAφC31 fragment into the MluI/NheI sites of pJL43.1. 
pMLV129: Pglh-2::3xHAφC31w/introns::glh-2 3’ UTR::emb-27(+): Digested 
pMLV124 with BamHI and XhoI to liberate a 5.1 Kb Pglh-2::3xHAφC31w/introns::glh-
2 3’ UTR fragment, then inserted into BglII/SalI site of pMLV126(described below).  
pMLV131: pMLV129 into pMLV127: An 8.1 kb StuI pMLV129 fragment was 
inserted into an NdeI site of pML127(described above).  
pMLV134: pEXP[Phsp-16.2::φC31::tbb-2 3’ UTR]: pCM1.56(gift from G. 
Seydoux), pMLV074 and pCM1.36 (gift from G. Seydoux) and cloned into pDESTR4-
R3 via gateway cloning (Invitrogen). 
pMLV135: pEXP[Phsp-16.2::φC31NLS::tbb-2 3’ UTR]: pCM1.56(gift from G. 
Seydoux), pMLV075 and pCM1.36 (gift from G. Seydoux) and cloned into pDESTR4-
R3 via gateway cloning (Invitrogen). 
pMLV136: pEXP[Phsp-16.2::H2BtagRFP::tbb-2 3’ UTR]: pCM1.56(gift from 
G. Seydoux), pMS25 (M. Sallee, unpublished) and pCM1.36 (gift from G. Seydoux) and 
cloned into pDESTR4-R3 via gateway cloning (Invitrogen). 
pMLV144: pDEST[R4-R3]emb-27(+): R3-R4 Gateway cassette was amplified 
from pDEST(R3-R4) (Invitrogen) using primers oMV0003 
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(caggatatccaactttgtatagaaaagtt) and oMV0004 (tacgatatccaactatgtataataaagtt) and 
AccuPrime pfx polymerase (Invitrogen), then digested with EcoRV and cloned into the 
AfeI site of pMLV126(described below). 
pMLV149: pDEST9626[R4-R3]emb-27(+): A 4.7 kb StuI pMLV144 fragment 
was inserted into an NdeI site of pML127 (described above). 
pMLV160: pEXP9626[Pmex-5(w/o ATG)::φC31::tbb-2 3’ UTR]emb-27: pJA252 
(gift from J. Arringher), pMLV074 and pCM1.36 (gift from G. Seydoux) and cloned into 
pMLV149 via gateway cloning (Invitrogen). 
pMLV168: pEXP9626[Ppie-1(w/o ATG)::φC31::tbb-2 3’ UTR]emb-27: 
pMLV114, pMLV074 and pCM1.36 (gift from G. Seydoux) and cloned into pMLV149 
via gateway cloning (Invitrogen). 
Heat-shock φC31 vectors: 
 
pMLV134: pEXP[Phsp-16.2::φC31::tbb-2 3’ UTR]: pCM1.56(gift from G. 
Seydoux), pMLV074 and pCM1.36 (gift from G. Seydoux) and cloned into pDESTR4-
R3 via gateway cloning (Invitrogen). 
pMLV135: pEXP[Phsp-16.2::φC31NLS::tbb-2 3’ UTR]: pCM1.56(gift from G. 
Seydoux), pMLV075 and pCM1.36 (gift from G. Seydoux) and cloned into pDESTR4-
R3 via gateway cloning (Invitrogen). 
pMLV136: pEXP[Phsp-16.2::H2BtagRFP::tbb-2 3’ UTR]: pCM1.56(gift from 
G. Seydoux), pMS25 (M. Sallee, unpublished) and pCM1.36 (gift from G. Seydoux) and 






pMLV067: pENTR(R1-R2)-CFP(gf15): Primers oDS24 
(caccggaccggtagaaaaaatgagtaaaggagaagaac) and oDS25 
(gaattcatcttaagatatcgctttgtatagttcatccatgcc) with gateway sites were used to amplify 
CFP(gf15) from L4663 (A. Fire, G. Seydoux, J. Ahnn and S. Xu, unpublished) and 
cloned into pDONR221 via gateway cloning (Invitrogen). 
pMLV068: pENTR(R1-2R)-mCherry(optimized): Primers oMV001 
(caccggaccggtagaaaaaatggtctcaaagggtgaag) and oMV002 
(gaattcatcttaaagcgctgccttatacaattcatccatgcc) with gateway sites were used to amplify 
mCherry(optimized) (McNally et al. 2006) and cloned into pDONR221 via gateway 
cloning (Invitrogen). 
pMLV082: pENTR(L4-R1)-Pmyo-3: Digested pCM1.56 with SalI and AgeI, then 
treated cut vector with Klenow fragment to generate a blunt-ends. Digested L4643 with 
HindIII and XbaI, treated cut vector with Klenow fragment to generate a blunt-ends. 
Inserted the 2.4 kb Pmyo-3 fragment into the SalI/AgeI sites of pCM1.56. 
pMLV114: pENTR(L4-R1)-Ppie-1(w/o ATG): Primers Ppie-1-QC-ATG-F 
(aaatcaaattttcttttccaggctcaaacaaagccgattgcc) and Ppie-1-QC-ATG-R 
(ggcaatcggctttgtttgagcctggaaaagaaaatttgattt) were used to perform site-directed 
mutagenesis on pCG142 (Merritt et al. 2008) to delete the ATG present in the promoter 
of pie-1. 
pMLV126: emb-27(+) rescue construct: A 3.0 kb region from upstream gene to 
the downstream gene of emb-27 was amplified from N2 genomic DNA using primers 
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emb-27-F (tgaacagctgaagttacacg) and emb-27-R (gccacccatccttcagcaaa) and AccuPrime 
pfx polymerase (Invitrogen) and cloned into pCR-BLUNT-II-TOPO (Invitrogen). 
Extra-chromosomal arrays: 
 
arEx1323 and arEx1324: This array was generated as a complex array by 
injecting pCW2.1(Pceh-22::GFP) digested with ScaI at 1 ng/µl, pMLV126 (emb-27(+)) 
digested with SmaI at 1 ng/µl, pMLV124(Pglh-2::3xHAφC31::glh-2 3’ UTR) digested 
with Ecl136II at 1 ng/µl and N2 genomic DNA digested with PvuII at 75 ng/µl into 
GG48 (emb-27(g48)). 
arEx1419: This array was generated as a complex array by injecting 
pMLV134(Phsp-16.2::φC31::tbb-2 3’ UTR) digested with ScaI at 1 ng/µl, 
pMLV085(attB::Pmyo-3::mCherry::unc-54 3’ UTR::attB) digested with ScaI at 1 ng/µl 
and N2 genomic DNA digested with PvuII at 75 ng/µl into GS5596 (arSi1/mnC1[dpy-
10(e128) unc-52(e444)]; unc-119(ed3)). 
arEx1457-arEx1460: This array was generated as a simple array by injecting 
pMLV134(Phsp-16.2::φC31::tbb-2 3’ UTR) at 50 ng/µl, and pMLV085(attB::Pmyo-
3::mCherry::unc-54 3’ UTR::attB) at 50 ng/µl into GS5596 (arSi1/mnC1[dpy-10(e128) 
unc-52(e444)]; unc-119(ed3)). 
arEx1461-arEx1464: This array was generated as a complex array by injecting 
pMLV134(Phsp-16.2::φC31::tbb-2 3’ UTR) digested with ScaI at 1 ng/µl, 
pMLV085(attB::Pmyo-3::mCherry::unc-54 3’ UTR::attB) digested with ScaI at 5 ng/µl 
and N2 genomic DNA digested with PvuII at 150 ng/µl into GS5596 (arSi1/mnC1[dpy-
10(e128) unc-52(e444)]; unc-119(ed3)). 
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arEx1468-arEx1470: This array was generated as a complex array by injecting 
pMLV095(Pmyo-3::CFP(g15)::unc-54 3’ UTR) digested with ScaI at 2 ng/µl, pMLV126 
(emb-27(+)) digested with SmaI at 1 ng/µl, pMLV136(Phsp-16.2::H2B-tagRFP::tbb-2 3’ 
UTR) digested with ScaI at 1 ng/µl and N2 genomic DNA digested with PvuII at 150 
ng/µl into GG48 (emb-27(g48)). 
arEx1471-arEx1473: This array was generated as a complex array by injecting 
pMLV095(Pmyo-3::CFP(g15)::unc-54 3’ UTR) digested with ScaI at 2 ng/µl, pMLV126 
(emb-27(+)) digested with SmaI at 1 ng/µl, pMLV134(Phsp-16.2::φC31::tbb-2 3’ UTR) 
digested with ScaI at 1 ng/µl and N2 genomic DNA digested with PvuII at 150 ng/µl into 
GG48 (emb-27(g48)). 
arEx1580-arEx1583: This array was generated as a simple array by injecting 
pMLV134(Phsp-16.2::φC31::tbb-2 3’ UTR) at 50 ng/µl, pMLV085(attB::Pmyo-
3::mCherry::unc-54 3’ UTR::attB) at 50 ng/µl and pBX (pha-1(+)) at 40 ng/µl into pha-
1(e2123). 
arEx1584-arEx1587: This array was generated as a complex array by injecting 
pMLV134(Phsp-16.2::φC31::tbb-2 3’ UTR) digested with ScaI at 1 ng/µl, 
pMLV085(attB::Pmyo-3::mCherry::unc-54 3’ UTR::attB) digested with ScaI at 5 ng/µl, 
pBX(pha-1(+)) digested with ScaI at 1 ng/µl and N2 genomic DNA digested with PvuII 
at 150 ng/µl into pha-1(e2123). 
arExMV83.3 and arExMV83.10: This array was generated as a simple array by 
injecting pMLV134(Phsp-16.2::φC31::tbb-2 3’ UTR) at 30 ng/µl, pMLV194(Prpl-
28::attP::pat-3::CFP::unc-54 3’UTR::attB::2xNLS::YFP::let-858 3’ UTR) at 30 ng/µl 




Single-copy insertion via MosSCI: 
 
Single-copy insertions of attP cassette into MosI transposable element sites were 
performed as described previously (Frøkjaer-Jensen et al. 2008). Transgenic worms were 
made by injecting into the following strains: GS5652 (ttTi5605; unc-119(ed3)); GS5653 
(unc-119(ed3); cxTi10882); GS5654 (unc-119(ed3); cxTi9393) or GS5655 (cxTi10471; 
unc-119(ed3)). The standard injection mix consisted of 50 ng/ml repair template, 50 
ng/ml Mos1 transposase, pJL43.1 (Pglh-2::transposase) (Bessereau et al. 2001) and 10 
ng/ml of p716 (Pmyo-3::mCherry) (Myers 2007). Injected worms were placed at 22 °C 
and screened for the presence of rescued worms without the Pmyo-3::mCherry co-
injection marker. 
Single-copy insertion of φC31 containing transgenes into MosI transposable 
element sites were based on work previously described (Frøkjaer-Jensen et al. 2008). 
Transgenic worms were made by injecting into the following strains: GS5780 (emb-
27(g48); ttTi9626). The standard injection mix consisted of 50 ng/ml repair template, 50 
ng/ml Mos1 transposase, pJL43.1 (Pglh-2::transposase) (Bessereau et al. 2001) and 10 
ng/ml of p716 (Pmyo-3::mCherry) (Myers 2007). Injected worms were placed at 15 °C 
for three day, then moved to 25 °C and screened for starved plates, which would indicate 
rescue of emb-27. Roughly a tenth of rescued starved plates were chunked to a freshly 
seeded plate and placed at 25 °C. Repeated this operation once more. Plates, in which the 
Pmyo-3::mCherry co-injection marker was not visible, were kept for further analysis. At 





mRNA co-injections: The plasmid pcDNA3.1_phiC31 (Bischof et al. 2007) or 
pMLV022 were linearized with the restriction enzyme BamHI, and capped mRNA was 
transcribed in-vitro according to the protocol of the mMESSAGE mMACHINE kit 
(Ambion). Co-injections of φC31 mRNAs and donor plasmids were diluted in nuclease-
free water (Ambion) at various concentrations. These mixes were injected into the C. 
elegans germline as previously described (Mello & Fire 1995). Injected worms were 
placed in 100 mm NGM plates, at 22 °C for three days, then moved to 15 °C for a week. 
F2s were screened for the presence of Unc worms. 
Direct injection: Co-injections of DNAs were diluted in nuclease-free water 
(Ambion) at various concentrations. These mixes were injected into the C. elegans 
germline as previously described (Mello & Fire 1995). Injected worms were placed in 
100 mm NGM plates, at 22 °C for three days, then moved to 15 °C for a week. F2s were 
screened for the presence of Unc worms. 
φC31-containing arrays: Germline-expressing φC31 containing arrays were 
crossed into GS5596 arSi1/mnC1[dpy-10(e128) unc-52(e444)]; unc-119(ed3). Donor 
plasmids were diluted into water and injected into the C. elegans germline as previously 
described (Mello & Fire 1995). Injected worms were placed in 100 mm NGM plates, at 
22 °C for three days, then moved to 15 °C for a week. F2s were screened for the presence 
of Unc worms. 
Heat-shocked arrays: Heat-shock promoter driven φC31 and donor plasmids 
containing arrays were directly injected into the germline of strain GS5596 
(arSi1/mnC1[dpy-10(e128) unc-52(e444)]; unc-119(ed3)) as previously described (Mello 
53
	  
& Fire 1995). Strains containing the arrays were bleached to collect semi-synchronous 
embryos, then were subjected to heat-shock treatments at 37 °C for 1 hour on days 0, 1 
and 2 after the egg prep. On day 3, L4 animals were transferred to 100 mm NGM plates 
seeded with OP50. About 10 L4s were placed on each plate. Animals were placed at 22 
°C for three days then moved to 15 °C for a week. F2s were screened for the presence of 
Unc worms. 
For experiments involving somatic RMCE and intramolecular recombination, 
semi-synchronous embryos were collected. Either embryos or L1/L2 animals were 
subjected to a 2 hour heat-shock at 33 °C or 37 °C. φC31 mediated recombination was 
confirmed by PCR or visualized under the dissecting scope. 
Single-copy φC31 strains: Donor plasmids were diluted into water and injected 
into the C. elegans germline as previously described (Mello & Fire 1995). Injected 
worms were placed in 100 mm NGM plates, at 22 °C for three days, then moved to 15 °C 
for a week. F2s were screened for the presence of Unc worms. 
Immunostaining.  
 
Immunostaining was performed as described previously(Finney & Ruvkun 1990). 
HA antibody staining was used as described previously (Karp & Greenwald 2003). 
Imaging. 
 
Images were acquired and scoring was performed on a Zeiss Axio Imager Z1 
microscope with an ApoTome system and a Hamamatsu ORCA-ER camera, or a Zeiss 




Results and Discussion: 
φC31 can mediate recombination in C. elegans: 
 
To determine whether φC31 integrase is active in C. elegans, I tested whether it 
could direct intramolecular excision of pat-3::CFP::unc-54 3’ UTR flanked by tandem 
attP and attB sites in somatic cells. If φC31 integrase is active there should be an excision 
of the intervening sequence, in this case it is pat-3::CFP::unc-54 3’ UTR, thus allowing 
the expression of the 2xNLS::YFP::let-858 3’ UTR (figure 3). Simple arrays containing 
the cassette and φC31 under a heat-shock promoter were made. Hermaphrodites carrying 
these arrays were subjected to heat-shock treatment at 33 °C for two hours during 
embryogenesis or the L1/L2 larval stages. Excision of pat-3::CFP was observed by the 
presence of 2xNLS::YFP expression. The frequency of excision was relatively the same 
between heat-shock treatment during embryogenesis or during early larval stages. Of 
three lines tested, all of them gave a high-percentage recombination frequency, with at 
least 95% of animals showing at least one recombination event. In animals carrying the 
arrays, without undergoing heat-shock treatment a few animals had 2xNLS::YFP 
expression, these were only intestinal cells, presumably due to leaky expression of φC31.   
Expression of 2xNLS::YFP was seen in heat-shocked animals in intestinal cells, 
pharyngeal cells, hypodermal cells and gonadal cells (figure 4). 
This experiment shows that φC31 is active in C. elegans and can mediate 
recombination between attP and attB sites. With the similarity of this technique with 
Flp/FRT and Cre/loxP recombination systems, it is possible to use some of the same 
strategies used in these other systems, including but not limited to expressing φC31 with 
a tissue-specific promoter to mark the lineages of those cells.  
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φC31 can mediate recombination in the C. elegans germline: 
 
A plasmid containing an attP site, pM(3xP3RFP-attP') (Bischof et al. 2007) was 
co-bombarded with an Ce unc-119 plasmid to establish lines with integrated attP sites. 
Injection of 20 P0 hermaphrodites, of pMLV001, containing an attB site and a muscle 
specific mCherry expressing transgene, with φC31 mRNA at 250 ng/ul, into the attP line 
was screened for proper segregation of the mCherry transgene. This generated one line 
that appeared to be integrated (table 1). An attempt was made to use less donor plasmid, 
which did not generate an integrated line. 
The integrated line was tested to discern whether it was produced by a φC31 
mediated-integration event (figure 5B and figure 5C). Lines that were thought to be 
extrachromosomal lines were also tested (figure 5B). PCR was used to detect the 
presence of the donor site, the attB site, and the presence of a φC31 recombination 
product, the attL site. If there is correct integration of the donor plasmid, there should be 
a loss of the attB and a gain of the attL site. And if an extrachromosomal array has been 
formed, there will not be a loss of the attB site or a gain of the attL site. In the integrated 
line 1, there is the presence of an attL site and the absence of an attB site present in the 
donor plasmid, suggesting that φC31 was able to mediate recombination between the attB 
site the attP in the germline. This provides evidence that φC31 is able to work in the 
germline to promote site-specific recombination.  
The ability to screen for the integration event was hampered by the low 
expression of the fluorescent transgene in low copy number. Furthermore, the bombarded 
attP line was integrated in multiple copies (data not shown). The revised approach below 
was attempted to circumvent the idiosyncrasies of C. elegans transgenesis. 
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Constructing suitable landing platforms in the C. elegans genome: 
 
At the time of devising a plan to incorporate transgenes into C. elegans using 
φC31, a new technique to target transgenes in single copy was being developed 
(Frøkjaer-Jensen et al. 2008). This technique, MosSCI, took advantage of the double-
strand break created in the genome by the excision of a transposable element. The repair 
of the double-strand break through homologous recombination is capable of introducing 
transgenes into the genome. This technique would be used for getting the attP landing 
site into the genome in single copy. At the beginning of the project presented in the 
thesis, there were only two Mos1 insertion sites that were characterized and shown to be 
suitable for MosSCI, ttTi5605 and ttTi10882 (Frøkjaer-Jensen et al. 2008). At the time of 
writing however, another 6 Mos1 sites have been shown to be suitable for transgenesis, 
krTi5271, krTi5273, ttTi4348, ttTi4391, cxTi10816 and ttTi14024 (Giordano-Santini et al. 
2010; Frøkjaer-Jensen et al. 2012). For the φC31 system to be viable, more than one site 
would need to be available. In addition to the Mos1 insertions ttTi5606 and ttTi10882, I 
also attempted MosSCI with the Mos1 insertions cxTi10471 and cxTi9393, which were 
unsuccessful. 
The propensity of injected DNA to form extrachromosomal arrays in C. elegans 
makes it difficult to screen for integration events by rescue of mutant worms or by the 
presence of a fluorescent protein. By using RMCE, it might be easier to find integration 
events, where a negative selectable marker could be used to select against non-
recombinants. It has been shown in D. melanogaster that RMCE works just as efficiently 
as WPI (Bateman et al. 2006; Bateman & Wu 2008). 
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Three components have gone into the landing platform (see figure 6B). A good 
fluorescent transgene was used, Pglt-3::venus::unc-54 3’ UTR that gives expression in 
the excretory canal cell and provides a way to follow the landing platform once it is 
integrated (Mano et al. 2007). Cb unc-119 was used for positive selection of the landing 
platform when integrated in single-copy as used in the MosSCI technique (Frøkjaer-
Jensen et al. 2008). I have used a transgene with the sup-7(st5) mutation as negative 
selectable marker. sup-7(st5) is a tryptophan tRNA with the tryptophan anti-codon 
mutated to recognize an amber stop (Waterston 1981; Wills et al. 1983; Bolten et al. 
1984). Homozygous sup-7(st5) animals are sterile at 15°C, and are fertile at 25°C.  
The efficiency of integration was much lower than it was reported for the known 
Mos1 insertion sites, ttTi5605 and cxTi10882 (Frøkjaer-Jensen et al. 2008 and Table 2). 
This is most likely due to the presence of sup-7(st5) in the landing platform, whose 
toxicity inhibits the formation of extrachromosomal arrays (Fire 1986; Mello et al. 1991). 
However, two lines at two different sites, ttTi5605 and cxTi10882, were obtained (table 2 
and figure 7). These two lines had the appropriate markers, were in the correct orientation 
and no aberrations were noticed by PCR (figure 7). No integrated lines were recovered 
from cxTi10471 and cxTi9393 Mos1 insertion sites. Attempts to investigate whether these 
insertion sites were suitable for MosSCI was not done. 
RMCE in the germline in C. elegans: 
 
mRNA injections of φC31 into the C. elegans germline: 
To circumvent the need for expressing φC31 in the germline, φC31 mRNA was 
transcribed in-vitro and co-injected with the donor plasmid. This method has been used 
successfully in D. melanogaster, although with low integration efficiency (Bateman et al. 
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2006; Bischof et al. 2007; Bateman & Wu 2008). Different concentrations of both mRNA 
and donor plasmids were tried. Only one RMCE event was recovered from injecting the 
φC31 mRNA at 1000 µg/µl and the donor plasmid at 50 ng/µl (table 3 and figure 9).  
It is possible that the 5’ UTR and 3’UTR of the in-vitro transcribed φC31 mRNA 
were not conducive to germline translation as sequences in the UTRs can influence the 
translation of germline expressing genes (Marin & Evans 2003; Wood et al. 2011). Thus, 
one could place φC31 in a context that is more suitable for germline translation. By 
placing a SL1 or SL2 sequence upstream of the start ATG and placing a 3’ UTR from a 
gene that is expressed in the germline, such as pie-1, downstream of φC31, the in-vitro 
transcribed mRNA might be more stable in the germline and/or translated at a higher 
frequency, thereby increasing the efficiency of RMCE. 
As the method to transcribe mRNA in-vitro is time consuming and expensive, it is 
not an ideal solution to express φC31 in the germline for the purpose of inserting 
transgenes in the genome of C. elegans. Several different methods of expressing φC31 in 
the germline were tried (see below).  
Expression of φC31 in the germline from extrachromosomal arrays: 
Different attempts to integrate the donor plasmids via RMCE into the C. elegans 
germline were performed (figure 8). As it was a successful strategy for MosSCI 
(Frøkjaer-Jensen et al. 2008), extra-chromosomal arrays were made with heat-shock 
driven φC31 and the donor plasmid. Hermaphrodites carrying these arrays were subjected 
to heat-shock treatment at 37°C for 1 hr. and the F1 and F2 progeny were screened for 
the RMCE event. However, these attempts were unsuccessful in generating germline 
integration (table 4).  
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Attempts to directly inject a plasmid with φC31 being driven by a germline 
specific promoter such as glh-2 or pie-1 and the donor plasmid together were done. This 
has been successful in MosSCI to get single-copy events at a reasonable frequency 
(Frøkjaer-Jensen et al. 2008). This was not a successful strategy at generating RMCE 
events in the germline (table 3). 
An extrachromosomal arrays was made containing a Pglh-2::3xHAφC31::glh-2 3’ 
UTR and an emb-27(+) rescuing plasmid was used to rescue emb-27(g48). The emb-
27(g48) mutation is a temperature sensitive mutation, that is viable at 15°C, but 
embryonic lethal at 25°C (Cassada et al. 1981). EMB-27 is part of the anaphase 
promoting complex required in the metaphase-to-anaphase transition for both mitosis and 
meiosis in the germline (Sadler & Shakes 2000; Golden et al. 2000; Rappleye et al. 2002; 
E. S. Davis et al. 2002; Yeong 2004). The germline requirement of emb-27 makes it a 
suitable candidate to use as a co-injection marker to ensure that the extrachromosomal 
array is not silenced in the germline. Indeed, complex extrachromosomal arrays 
containing Pglh-2::3xHAφC31::glh-2 3’ UTR and emb-27(+), which rescue emb-27(g48) 
embryonic lethality at 25°C, do appear to have expression of the φC31 in the germline by 
antibody staining against the HA tag (data not shown). However, attempts to recover 
RMCE events with these arrays were not fruitful (table 3). 
Integrated φC31 transgenes: 
The optimal solution towards expressing φC31 in the germline, would be to 
integrate a φC31 transgene into the C. elegans genome. This has been successful in D. 
melanogaster to significantly increase the efficiency of φC31 mediated integration 
(Bischof et al. 2007). An attempt was made to insert Pglh-2::3xHAφC31::glh-2 3’ UTR 
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into the genome as a single copy using MosSCI. Instead of using unc-119(ed3) rescue to 
isolate potential candidates, rescue of emb-27(g48) was used. The Mos1 insertion site 
ttTi9626 was used to attempt this integration (figure 6). An integrant was isolated that 
appears to have inserted correctly (table 5). An attempt was made to integrate a donor 
plasmid into the landing platform in the germline using this transgenes without success 
(table 4).  
It is possible that this φC31 is not being expressed in the germline of the 
transgene. To address this possibility, I have made two germline expressing φC31 vector 
constructs, where well-characterized germline promoters are driving φC31 integrase. 
Two different promoters are being tested, mex-5 and pie-1 promoters that have been 
shown to express GFP in the germline in single copy (Frøkjaer-Jensen et al. 2008; Zeiser 
et al. 2011). However, time did not allow adequate examination of these transgenes to 




In this chapter, I describe an attempt to use φC31 integrase to insert transgenes in 
the C. elegans genome. I show that φC31 is active in C. elegans and that φC31 mediated 
integration can occur in the C. elegans germline using injected mRNA though it is rare. 
Until a φC31 germline expressing strain is established, I cannot say whether φC31 would 
be a viable method to integrate transgenes into the genome. Work in Drosophila suggests 
that stably expressing lines will increase efficiency of integration. It is worth noting that I 
61
	  
haven’t shown that it couldn’t work for integrating transgenes in the C. elegans germline. 
I will make more comments about φC31 in Chapter 4. 
In the course of this work I have developed a new MosSCI site where single copy 
integration is possible. Although I haven’t shown whether it is suitable for germline 
expression. This adds to the list of possible sites where MosSCI has been tried. It is worth 
pointing out that in about half of the Mos1 sites, where MoSCI has been tried, no 
germline expression is seen (Frøkjaer-Jensen et al. 2012). To complicate matters even 
further, of the appropriate Mos1 sites, one third of integrated germline specific transgenes 
are expressed correctly in the germline (Frøkjaer-Jensen et al. 2008).  
I also developed a new selectable marker for MosSCI by using emb-27 rescue. 
The efficiency of integration of using emb-27 rescue is comparable to unc-119 rescue. 
Using emb-27 rescue I was able to get integration efficiency close to what has been 
reported with unc-119 rescue (Frøkjaer-Jensen et al. 2008 and Table 5). This adds to list 
of possible selection markers for MosSCI, including resistance against the antibiotics 
Puromycin and Neomycin (Semple et al. 2010; Giordano-Santini et al. 2010).   
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Chapter 2: Figures and Tables. 
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Figure 1. Transgenes in C. elegans.
A.) Schematic of extrachromosomal formation.
B.) Schematic of integrating extrachromosomal arrays by irradiation.
C.) Schematic of micro-particle bombardment. Gold particles are coated with plasmids and bom-
barded into C. elegans. Integration of plasmids is random and at low-copy number.
D.) Mos1 single-copy insertion (MosSCI). Single-copy insertion via gene conversion induced by 




































Figure 2. φC31 mediated integration.
A.) Schematic of φC31 mediated recombination between the attachment sites attB and attP 
which gives rise to the hybrid sites attR and attL. The φC31 recombination is unidirectional.
B.) Core DNA sequence of the different φC31 attachment sites, attB in bold and attP in light. 
The resulting hybrid sites, attR and attL are shown as well. Recombination cross-over event oc-
curs within the underlined sequence.
C.) Schematic of two different techniques for φC31-mediated transgene insertion. One employs 
the use of a single attP site already inserted in the genome in single-copy, where φC31 mediates 
the integration of a donor plasmid containing a single attB site with the single attP site. The other 
technique, recombination mediated cassette exchange (RMCE), employs the use of a cassette 
flanked by two attP sites, which has been inserted in the genome. A donor plasmid containing a 
gene of interest is flanked by two attB sites. φC31 mediates recombination between the att sites, 













Figure 3: φC31 mediated cassette excision in C. elegans.
A.) Schematic of φC31-mediated excision of fluorescent protein, between the attachment 















Figure 4: Evidence for φC31 mediated cassette excision in C. elegans.
Expression of 2xNLS::YFP is not seen in the no heat-shock control (A-D). Expression of 
2xNLS::YFP after heat-shock (E-H). Expression is seen in the posterior pharynx bulb and hypo-
dermal cells in the head (F) and in vulva precursor cells, ventral neurons, somatic gonad and in-
testine (H). PAT-3::CFP is expressed under the ubiquitous rpl-28 promoter (A,C,E and G). Green 












a Number of P0  animals injected.
b mCherry expression of F1 animals indicate the minimum frequency of successful gonad injec-
tion.
b The integrated line was assessed by PCR.
Table 1: Insertion of transgenes via φC31.







pMLV001 (50 ng/μl) - 20 11 12 0
pMLV001 (50 ng/μl) mRNA (250 ng/μl) 20 9 15 1


























Figure 5: WPI of transgenes in C. elegans via φC31.
A.)  Brief schematic showing the integration of a plasmid containing Pmyo-3::mCherry and an 
attB site into a strain in which an attP site was bombarded into the genome.
B.) PCR showing evidence for φC31 mediated integration. Four Pmyo-3::mCherry expressing 
stable lines resulting from a co-injection of φC31 mRNA and pMLV001 were tested. Only line 1 
showed segragation of Pmyo-3::mCherry consistent with it being integrated. The lanes attP and 
attB are plasmids containing the respective att sites, which are serving as controls. Line 1 shows 
a loss of the attB site, which should be present in pMLV001 and any extrachromosomal arrays 
formed from pMLV001. In line 1 there is also the presence for an attL site. The presence of an 
attL site combined with the loss of an attB in Line 1, provides evidence that the pMLV001 was 
integrated into the genome via φC31 mediated recombination.
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Mos1 insertion site
Figure 6: Insertion of attP cassette into the genome via MosSCI.
A.) Location of Mos1 transposons. ttTi5605, cxTi10882, krTi5271 and krTi5273 are Mos1 inser-
tion which have been shown capable of accepting transgenes via MosSCI (Frøkjær-Jensen et al., 
2008; Giordano-Santini et al., 2010). Introduction of transgenes into Mos1 insertions, cxTi10471, 
cxTi9393 and ttTi9626, were attempted in this work.
B.) The MosSCI technique allows for insertion into a unique, single genomic locus (Robert and 
Bessereau, 2007; Frøkjær-Jensen et al., 2008) via gene conversion induced by the excision of the 
Mos1 transposable element. This approach was used to insert a single copy of an attP cassette 
containing; Pglt-3::venus::unc-54 3’ UTR visible marker, Cb unc-119(+) rescue fragment and 
sup-7(st5) negative selectable marker.
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cxTi10471; unc-119(ed3) pMLV098 420 0 0
ttTi5605; unc-119(ed3) pMLV093 182 1 1
unc-119(ed3); cxTi10882 pMLV099 452 2 1
unc-119(ed3); cxTi9393 pMLV115 420 0 0
Table 2: Integration of attP cassette into the genome by MosSCI.
a Mos1 transposon insertion strains attempted for MosSCI inserts of landing platforms.
b Repair templates containing the landing platform (attP::Pglt-3::Venus::unc-54 3’ UTR::Cb unc-
119::sup-7(st5)::attP) which were injected into their respective strain.
c Number of P0 animals injected.
d Integrants were selected based on the unc-119 rescue and the expression of Venus in the excre-
tory cell. The presence of sup-7(st5) in the landing platform selects against the stable formation 
of extrachromosomal arrays.






























































































































































































































































































































































































































































































































































































































































































































































































Figure 8: Overview of φC31 mediated insertion of transgenes in C. elegans.
A.) Schematic of RMCE of Pmyo-3::mCherry transgene from an extrachromosomal array. The 
landing platform containing the attP cassette has been inserted in single-copy at a known locus. 
φC31 is expressed under the control of a heat-shock promoter from the extrachromosomal array 
containing Pmyo-3::mCherry flanked by attB sites. Correct insertion of the transgene is assessed 
by the loss of unc-119(+) rescue, loss of Pglt-3::Venus expression and the loss of sup-7(st5) 
negative selectable marker.
B.) Schematic of RMCE of Pmyo-3::mCherry. The landing platform containing the attP cas-
sette has been inserted in single-copy at a known locus. Pmyo-3::mCherry flanked by attB sites 
is directly injected into the gonad of worms expressing φC31 or in some cases co-injected with 
φC31 mRNA(see Materials and Methods). Correct insertion of the transgene is assessed as above 
(figure 3a).
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GS5595g mRNA (500 ng/μl) pMLV085 (50 ng/μl) 79 34 0
GS5595g mRNA (1000 ng/μl) pMLV085 (50 ng/μl) 82 52 0
GS5596 mRNA (250 ng/μl) pMLV085 (50 ng/μl) 125 68 0
GS5596 mRNA (1000 ng/μl) pMLV085 (50 ng/μl) 42 19 1h
GS5596 mRNA (1000 ng/μl) pMLV085 (250 ng/μl) 90 64 0
GS5595g pMLV080i (50 ng/μl) pMLV085 (50 ng/μl) 80 32 0
GS5595g pMLV081j (50 ng/μl) pMLV085 (50 ng/μl) 44 32 0
GS5596 pMLV081j (50 ng/μl) pMLV085 (50 ng/μl) 42 22 0
GS5596 pMLV124k (50 ng/μl) pMLV085 (50 ng/μl) 122 84 0
NA arEx1323l pMLV085 (50 ng/μl) 131 99 0
GS6095 arSi3m pMLV085 (50 ng/μl) 40 24 0
a Strain containing the landing platform arSi1.
 
b Source of φC31. mRNA, DNA and transgene provided φC31.
c Donor plasmid injected and concentration used.
d Number of P0  animals injected.
e mCherry expression of F1 animals indicate the frequency of successful gonad injection.
f Successful RMCE event was assessed by the loss unc-119 rescue, loss of excretory cell Venus 
expression and mCherry expression. 
g In the strain GS5595, as the landing platform, arSi1, was not balanced, the strain gave rise to 
Unc progeny. Screening for RMCE event during injection of this strain required the presence of 
mCherry expression and correct segregation of the transgene.
h Correct insertion of the Pmyo-3::mCherry::unc-54 3’ UTR was verified by PCR analysis (see 
Figure 4).
i Co-injection of Pglh-2::φC31::glh-2 3’ UTR with donor plasmid.
j Co-injection of Ppie-1(short)::φC31::glh-2 3’ UTR with donor plasmid.
k Co-injection of Pglh-2::3xHAφC31w/introns::glh-2 3’ UTR with donor plasmid.
l arEx1323[Pglh-2::3xHAφC31w/introns::glh-2 3’ UTR] was generated in an emb-27(g48) back-
ground crossed into strain GS5596.
m Integration of Pglh-2::3xHAφC31w/introns::glh-2 3’ UTR via MosSCI (see Table 5).
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GS6097 arEx1419 complexf 120 0
GS6276 arEx1457 simple 100 0
GS6277 arEx1458 simple 100 0
GS6282 arEx1463 complexg 100 0
GS6283 arEx1464 complexg 100 0
Table 4: RMCE attempts via heat-shock driven φC31.
a Strain containing the landing platform arSi1.
 
b Extrachromosamal array.
c Both simple and complex arrays were used.
d Number of P0  animals screened after the heat-shock treatment.
 
e Successful RMCE event was assessed by the loss unc-119 rescue, loss of excretory cell Venus 
expression and mCherry expression. 
f C. elegans genomic DNA was injected at 75 ng/μl.









Figure 9: Verification of RMCE in the germline by φC31.
A.)  Schematic of the genomic location after the RMCE event, showing the positive orientation 
in which the transgene could be inserted. The numbers correspond to primers used for checking 
correct integration.
B.) Transgene insertion at target site was confirmed by PCR. Different sets of primers were used 
to verify the correct insertion of the transgene. The asterisk in lane N, denote background bands 










Lanes A B C D E F G H I J K L M N
Primer Pairs 5-4 5-8 1-4 6-4 1-8 6-8 5-3 5-9 2-3 2-9 7-3 7-9 5-5 1-2
Expected Sizes (Kb) 0.56 1.90 1.96 2.72 3.35 4.11 1.01 1.35 2.44 2.77 3.12 3.46 4.63 7.47
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pMLV131 50 ng/μl 132 36 3 1
pMLV160 50 ng/μl 80 38 9 4
pMLV168 50 ng/μl 80 53 8 3
pMLV160 2 ng/μl 80 9 1 1
pMLV168 2 ng/μl 80 7 1 1
Table 5: Integration of germline-expressing φC31 transgenes into the genome by MosSCI.
a Mos1 transposon insertion strain used was GS5780: emb-27(g48); ttTi9626. 
b Different concentration of repair template was attempted, as it had been reported that it can af-
fect germline expression of transgenes.
c Number of P0 animals injected.
d Integrants were selected based on the emb-27 rescue and the loss of mCherry expression in 
muscle tissue.


























Figure 10: Vectors for φC31 mediated RMCE.
Three vectors for φC31 mediated recombination. One plasmid with multiple cloning sites for 
conventional cloning and two plasmids with Invitrogen’s Gateway cassettes, using both the [R1-










Figure 11: Expression of heat-shock promoter.
Expression of Phsp-16.2::H2BtagRFP::tbb-2 3’ UTR. (A-C) arEx1468. (D-F) arEx1469. (A-E) 
L4 and young adults, showing DIC and the TagRFP. After heat-shock treatment at 37°C for 1 hr. 
Expression is seen in the somatic gonad but not in the germline (seen in A-E), the intestine, the 
hypodermis and the head (not shown). H2BtagRFP expression in the embryo. One of the embry-
os does not contain the array (F and F’).
DIC TagRFP
DIC TagRFP




Chapter 3: Modulation of Notch 





   
The γ-secretase complex is an important component in the Notch signaling 
pathway. Not only is the γ-secretase complex involved in the Notch pathway, it is also 
implicated in the pathology of familial Alzheimer’s disease (FAD). As γ-secretase 
complex components show a Notch loss-of-function phenotype in C. elegans, a targeted 
approach was done to find new Notch modulators. A set of genes shown to interact 
biochemically (Wakabayashi et al. 2009) with the γ-secretase complex was screened for 
suppression and enhancement of Notch in the C. elegans germline. Knockdown of 
several genes show suppression of a Notch gain-of-function allele, glp-1(ar202), while 
knockdown of these genes show no interaction of a Notch loss-of-function allele, glp-
1(bn18). This allele-specificity suggests that the glp-1(ar202) suppressors are not integral 
Notch components. Surprisingly, one of the candidates, rab-11.2, was able to suppress 




The GLP-1 and LIN-12 Notch proteins mediate cell-cell interactions during the 
development of C. elegans. They are involved in many cell fate decisions in the embryo, 
larvae and the adult. Notch is presented to the cell surface as a heterodimer. Prior to its 
trafficking to the cell surface, Notch undergoes a proteolytic cleavage in the extracellular 
domain in between the N-terminal and C-terminal heterodimer domains. The Furin class 
of proteases mediates this S1 cleavage step. Once Notch is bound by a family member of 
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the Delta/Serrate/Lag-2 (DSL) ligands at the EGF repeats in the extracellular domain of 
Notch, it undergoes two rounds of proteolytic cleavages. The first of the cleavages, the 
S2 cleavage event, occurs in the extracellular domain, and is mediated by the 
metalloproteases SUP-17/Kuzbanian or ADM-4/TACE (Wen et al. 1997; Jarriault & 
Greenwald 2005). The second cleavage step occurs within the transmembrane domain 
and it is called S3 cleavage, which releases the Notch intracellular domain from the 
membrane. The S3 cleavage is mediated by the SEL-12/HOP-1 presenilin containing γ-
secretase complex (Levitan & Greenwald 1995; X. Li & Greenwald 1997; Westlund et al. 
1999). The Notch intracellular domain (NICD) is released and translocates to the nucleus 
to form a tripartite complex with the sequence-specific DNA binding protein LAG-
1/RBP-J and the co-activator SEL-8/MAM to activate transcription of target genes 
(Struhl et al. 1993; Jarriault et al. 1995; Christensen et al. 1996; Roehl et al. 1996; L. Wu 
et al. 2000; Petcherski & Kimble 2000). 
The γ-secretase complex contains a presenilin, SEL-12 or HOP-1, and includes 
three other components: APH-1, a seven transmembrane domain protein, APH-2, a type I 
integral membrane protein thought to be the substrate receptor for γ-secretase and PEN-2, 
a small protein with two transmembrane domains (Kimberly et al. 2003; Edbauer et al. 
2003). The presenilins provide the catalytic activity of the complex (Wolfe et al. 1999). 
The γ-secretase complex has been co-opted by the Notch pathway as mutations in the 
Presenilin catalytic subunits, sel-12 and hop-1, phenocopies loss of Notch signaling (X. 
Li & Greenwald 1997; Westlund et al. 1999).  
Although it appears that the main function of the γ-secretase complex is to 
promote Notch signaling, there have been other γ-secretase substrates identified 
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(reviewed in Parks & Curtis 2007). The most important of these substrates is the protein 
APP, whose processing by γ-secretase complex leads to the accumulation of Aβ peptides, 
which are found in amyloid plaques of patients suffering from Alzheimer’s disease (Kang 
et al. 1987; Goate et al. 1991; Scheuner et al. 1996). Like Notch, the extracellular domain 
of APP undergoes a couple of rounds of proteolytic cleavages. In neurons, APP is 
cleaved at the S2 site by the BACE protease and then cleaved at the S3 site by the γ-
secretase complex (De Strooper et al. 1998; Vassar et al. 1999). Normally, the γ-secretase 
complex generates a 40 amino acid peptide known as Aβ40 and also a minor larger 
peptide species, Aβ42. Mutations in PS1 found in some FAD patients cause an error in the 
processing of the extracellular domain of APP, favoring the production of the larger Aβ42 
peptide. The two extra amino acids in the Aβ42 peptide cause a propensity for the Aβ 
peptide to aggregate, which is thought to be the cause of plaque formation and 
progression of Alzheimer’s disease (Scheuner et al. 1996). 
Genetic analysis identified the core components of the γ-secretase complex. In 
humans, the Presenilin locus was first identified in genetic linkage studies for Familial 
Alzheirmer’s Disease (FAD) families (Schellenberg et al. 1992; Van Broeckhoven et al. 
1992; St George Hyslop et al. 1992; Sherrington et al. 1995). In C. elegans, in a genetic 
screen for suppression of a gain-of-function lin-12 allele, the worm orthologue, sel-12 
was identified as a Notch pathway component (Levitan & Greenwald 1995).  
A genetic locus which contains Nicastrin, a core component of the γ-secretase 
complex was identified in genetic linkage studies of FAD families (Zubenko et al. 1998; 
Kehoe et al. 1999). Subsequent genetic analysis revealed that polymorphisms in Nicastrin 
are not indicative of AD pathologies (Orlacchio et al. 2002; Confaloni et al. 2003). 
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Instead, biochemical studies identified Nicastrin as PS1 interactor in mammalian cell 
lines (Yu et al. 2000). In C. elegans, a screen for genes involved in the development of 
the anterior pharynx found APH-2, the C. elegans Nicastin orthologue (Goutte et al. 
2000). The aph-2 gene was subsequently found to genetically interact with lin-12 
(Levitan et al. 2001) In the same screen another γ-secretase component APH-1 was 
uncovered (Goutte et al. 2002). In another screen for enhancement of a sel-12 loss-of-
function mutation in C. elegans, yet another component of the γ-secretase was found; 
PEN-2 (Francis et al. 2002).  
Null mutations in these three components of γ-secretase complex display 
phenotypes that are associated with the loss of Notch signaling in C. elegans, mainly they 
have maternal-effect lethal (Mel) and have a loss of anterior pharynx (Aph) phenotypes 
(Goutte et al. 2000; Goutte et al. 2002; Levitan et al. 2001; Francis et al. 2002). They also 
interact genetically with components of the notch pathway (Levitan et al. 2001; Francis et 
al. 2002). 
There has been an interest in the γ-secretase complex, not only in its relation to 
Notch signaling but also to APP processing. In an attempt to better understand the γ-
secretase complex, Wakabayashi et al. pulled down the γ-secretase complex and 
identified proteins that were associated with γ-secretase by mass-spectrophotometry. 
They were successful in identifying the tetraspanins, CD81 and CD9, in their 
involvement in the processing of APP by the γ-secretase complex. In a separate study, 
originating with genetic analysis in C. elegans, the mammalian tetraspanins, TSPAN33 
and TSPAN5, were found to be required in Notch signaling at the level of γ-secretase 
activity, while CD81 did not affect Notch processing (Dunn et al. 2010). This leads to an 
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intriguing possibility that there might be accessory proteins that differentially promote 
the processing of γ-secretase substrates. 
 Wakabayashi et al. indentified 54 other proteins that were associated with the γ-
secretase complex. Among the proteins identified were: P24A, V-ATPase subunit A, and 
V-ATPase subunit d1. The gene p24a, which is homologous to sel-9 in C. elegans, was 
identified as a suppressor of a hypomorphic of C. elegans Notch receptor lin-12 
(Sundaram & Greenwald 1993; Wen & Greenwald 1999). The V-ATPase subunits were 
found to be involved in Notch signaling and endosomal trafficking in Drosophila 
melanogaster (Yan et al. 2009; Vaccari et al. 2008) A subset of the 56 proteins were 
tested by Wakabayashi et al. for their effect on APP processing in tissue culture assays. 
Effects on Notch processing were not tested. Thus, the list of γ-secretase associated 
proteins from the work of Wakabayashi et al. could contain potential novel Notch 
modulators. 




Caenorhabditis elegans var. Bristol strain N2 was the wild-type parent strain of all 
mutants and markers used. Key strains used herein were:  
GS4691: rhIs4[glr-1::gfp, dpy20(+)] 
GC143: glp-1(ar202) 





GS5818: rrf-3(pk1426); lag-2(q420) 
GS5819: eri-1(mg366); lag-2(q420) 


















GS6479: +/nT1; hmp-1(fe4)/nT1[qIs51] 
GS6190: sup-17(n1258); rhIs4[glr-1::gfp, dpy-20(+)] 
GS6070: rhIs4[glr-1::gfp, dpy-20(+)]; adm-4(ok265) 
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GS6060: rhIs4[glr-1::gfp, dpy-20(+)]; sel-12(ok2078) 
GS6069: hop-1(ar179); rhIs4[glr-1::gfp, dpy-20(+)] 
GS6176: rhIs4[glr-1::gfp, dpy-20(+)]; erl-1(tm2703) 
GS6177: rhIs4[glr-1::gfp, dpy-20(+)]; R09B5.11(ok1759) 
GS6178: rhIs4[glr-1::gfp, dpy-20(+)]; F53H8.3(ok3175) 
GS6179: H17B01.1(tm3165); rhIs4[glr-1::gfp, dpy-20(+)] 
GS6181: H17B01.1(tm3165); rhIs4[glr-1::gfp, dpy-20(+)]; R09B5.11(ok1759); 
F53H8.3(ok3175) 
GS6183: cdc-48.1(tm544); rhIs4[glr-1::gfp, dpy-20(+)] 
GS6184: cdc-48.2(tm659); rhIs4[glr-1::gfp, dpy-20(+)] 
GS6061: rhIs4[glr-1::gfp, dpy-20(+)]; atgp-1(ok388) 
GS6062: atgp-2(ok532); rhIs4[glr-1::gfp, dpy-20(+)] 
GS6063: rab-11(tm2081); rhIs4[glr-1::gfp, dpy-20(+)] 
GS6192: gpa-16(it143); rhIs4[glr-1::gfp, dpy-20(+)] 
GS6193: goa-1(n363); rhIs4[glr-1::gfp, dpy-20(+)] 
GS5814: rhIs4[glr-1::gfp, dpy-20(+)]; tsp-9(tm378) 
GS5899: rhIs4[glr-1::gfp, dpy-20(+)]; bar-1(ga80) 
GS6185: rhIs4[glr-1::gfp, dpy-20(+)]; sec-22(ok3053) 
GS6189: rhIs4[glr-1::gfp, dpy-20(+)]; hmp-1(fe4) 
GS6261: sup-17(n1258); glp-1(ar202) 
GS6260: glp-1(ar202); adm-4(ok265) 
GS6263: glp-1(ar202); sel-12(ok2078) 
GS6262: hop-1(ar179; glp-1(ar202) 
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GS6216: glp-1(ar202); erl-1(tm2703) 
GS6217: glp-1(ar202); R09B5.11(ok1759) 
GS6218: glp-1(ar202); F53H8.3(ok3175) 
GS6219: H17B01.1(tm3165); glp-1(ar202) 
GS6221: H17B01.1(tm3165); glp-1(ar202); R09B5.11(ok1759); F53H8.3(ok3175) 
GS6222: cdc-48.1(tm544); glp-1(ar202) 
GS6223: cdc-48.2(tm659); glp-1(ar202) 
GS6224: glp-1(ar202); bar-1(ga80) 
GS6225: rab-11.2(tm2081); glp-1(ar202) 
GS6226: glp-1(ar202); atgp-1(ok388) 
GS6227: atgp-2(ok532); glp-1(ar202) 
GS6228: atgp-2(ok532); glp-1(ar202); atgp-1(ok388) 
GS6287: gpa-16(it143); glp-1(ar202) 
GS6285: goa-1(n363); glp-1(ar202) 
GS5898: glp-1(ar202); tsp-9(tm378) 
GS6007: glp-1(ar202); sec-22(ok3053) 
GS6475: glp-1(ar202); gpa-4(pk381) 
GS6477: glp-1(ar202); +/nT1; hmp-1(fe4)/nT1[qIs51] 
GS6265: sup-17(n1258); glp-1(bn18) 
GS6264: glp-1(bn18); adm-4(ok265) 
GS6267: glp-1(bn18); sel-12(ok2078) 




GS6233: glp-1(bn18); erl-1(tm2703) 
GS6234: glp-1(bn18); R09B5.11(ok1759) 
GS6235: glp-1(bn18); F53H8.3(ok3175) 
GS6236: H17B01.1(tm3165); glp-1(bn18) 
GS6238: H17B01.1(tm3165); glp-1(bn18); R09B5.11(ok1759); F53H8.3(ok3175) 
GS6239: cdc-48.1(tm544); glp-1(bn18) 
GS6240: cdc-48.2(tm659); glp-1(bn18) 
GS6242: glp-1(bn18); bar-1(ga80) 
GS6243: rab-11.2(tm2081); glp-1(bn18) 
GS6244: glp-1(bn18); atgp-1(ok388) 
GS6245: atgp-2(ok532); glp-1(bn18) 
GS6246: atgp-2(ok532); glp-1(bn18); atgp-1(ok388) 
GS6286: gpa-16(it143); glp-1(bn18) 
GS6284: goa-1(n363); glp-1(bn18) 
GS6247: glp-1(bn18); tsp-9(tm378) 
GS6241: glp-1(bn18); sec-22(ok3053) 
GS6476: glp-1(bn18); gpa-4(pk381) 
GS6478: glp-1(bn18); +/nT1; hmp-1(fe4)/nT1[qIs51] 
GS6481: erl-1(tm2703); lag-2(q420) 
Strains carrying glp-1(ar202); glp-1(bn18) and lag-2(q420) were maintained at 15 °C, 





The conserved list was compiled from the data of Wakabayashi et. al. 
(Wakabayashi et al. 2009). The compiled list was put though Biomart in the Ensembl 
database to retrieve conserved C. elegans genes (Smedley et al. 2009; Vilella et al. 2009; 
Flicek et al. 2011). The resulting list was double-checked against Treefam and 
HomoloGene databases for homologous genes (H. Li et al. 2006; Ruan et al. 2008; 




Feeding RNAi experiments for suppression of glp-1(ar202) were performed as 
previously described (Dunn et al. 2010). Individual bacterial strains producing double-
stranded RNA (dsRNA) targeting the 46 C. elegans orthologues of the Presenilin pull-
down list we obtained (Kamath & Ahringer 2003). Gravid adults were bleached and eggs 
were placed on unseeded plates at 15 °C. Starved, synchronized, L1- stage glp-1(ar202) 
hermaphrodites were placed on dsRNA-expressing bacteria, and plates were shifted to 25 
°C for three days. The production of progeny, eggs and/or oocytes was evidence of 
suppression. 
Feeding RNAi experiments for the enhancement of lag-2(q420) were performed 
as previously described (Timmons et al. 2001; Timmons et al. 2003), with the following 
modifications: L4 hermaphrodites were placed on dsRNA-expressing bacteria at 15 °C. 
Hermaphrodites were transferred to fresh dsRNA-expressing bacteria, for three 
consecutive days. Each plate was scored for Emb (Embryonic lethal), Lag (lin-12 and 






For scoring sterility of glp-1(ar202), gravid adults were bleached and the eggs 
were placed on seeded OP50 plates at 15°C for 18-24hrs, then they were shifted to 25°C 
for 1 day. L4 animas were individually placed on fresh OP50 NGM plates at 25°C and 
scored 2 days later. The production of progeny, eggs and/or oocytes was scored to 
determine the degree of suppression. 
For scoring enhancement of sterility of glp-1(bn18), gravid adults were bleached 
and the eggs were placed on seeded OP50 plates at 15°C for 18-24hrs, then they were 
shifted to 20°C for 1 day. L4 animals were individually placed on fresh OP50 NGM 
plates at 20°C and scored 2 days later. glp-1(bn18) is not sterile on its own at 20°C. The 
production of progeny, eggs and/or oocytes was scored to determine the degree of 
enhancement. 
For scoring enhancement of embryonic lethality of glp-1(bn18), L4 animals were 
placed on OP50 seeded NGM plates and shifted 20°C. Hermaphrodites were transferred 
to fresh OP50 seeded NGM plates for 3 consecutive days and their progeny were 
assessed for Emb, two days later. 
For scoring suppression of sterility of glp-1(bn18), gravid adults were bleached 
and the eggs were placed on seeded OP50 plates at 15°C for 18-24hrs, then they were 
shifted to 23°C for 1 day. L4 animas were individually placed on fresh OP50 NGM plates 
at 23°C and scored 2 days later. The production of progeny, eggs and/or oocytes was 
scored to determine the degree of enhancement. 
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For scoring suppression of embryonic lethality of glp-1(bn18), L4 animals were 
placed on OP50 seeded NGM plates and shifted 23°C. Hermaphrodites were transferred 
to fresh OP50 seeded NGM plates for 3 consecutive days and their progeny were 
assessed for viability two days later. 
Results: 
 
RNAi screen for positive modulators of Notch in C. elegans. 
 
Gain-of-function alleles of glp-1 cause tumor formation in the germline due to 
over-proliferating mitotic cells (Berry et al. 1997; Pepper et al. 2003). In the case of 
weaker gain-of-function alleles, a proximal tumor, consisting of mitotic cells develops, 
and late onset tumors develop in the distal germline (Pepper et al. 2003). These alleles 
tend to be temperature-sensitive, such that at 15 °C their germline develops normally and 
at 25 °C the tumorous phenotypes appear. The animals become sterile at 25°C due to the 
tumors that develop in the germline. One weak allele that has been uncovered is glp-
1(ar202). RNAi against components of the notch pathway can suppress the activity of 
gain-of-function glp-1(ar202) allele, and thus can suppress the sterile phenotype of glp-
1(ar202) (Jarriault & Greenwald 2005; Dunn et al. 2010). 
To test which presenilin interacting protein is a possible positive modulator of 
Notch in C. elegans, RNAi feeding clones of the 46 C. elegans orthologues of the 
proteins identified in a human presenilin pull-down assay were fed to glp-1(ar202) 
hermaphrodite at 25 °C. Errors in some of the clones sequenced after the screen was 
completed suggest that not all 46 C. elegans orthologues were screened. However, the 
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positives from the screen were correct. The positives, H17B01.1 and erl-1 were identified 
through this screen as suppressing glp-1(ar202) by RNAi (table 3).  
The gene H17B01.1 is orthologous to the vertebrate class I glucose transporters, 
which include hGLUT1. In C. elegans there are an additional two class I glucose 
transporter that are “in”-paralogues” to H17B01.1, these are: F53H8.3 and R09B05.11. 
These paralogues were also used for further analysis. The gene erl-1 is orthologous to the 
vertebrate ERLIN, which stand for ER lipid rafts.  
To determine whether the RNAi effects were due to a suppression of GLP-
1/Notch signaling or due to an effect on germline proliferation, we first attempted RNAi 
against a temperature-sensitive allele of lag-2, a DSL ligand, which is necessary for 
sending the Notch signal. The allele lag-2(q420) is a missense mutation in a splice 
acceptor, such that at 15 °C enough WT protein is made to allow for Notch signaling to 
occur, though at 25 °C there is not enough full-length mRNA made leading to loss-of-
function phenotypes (Lambie & Kimble 1991; Henderson et al. 1994). The phenotype 
displayed is reminiscent of lin-12(lf) glp-1(lf) double mutants, hence the name of the 
phenotype, Lag for Lin-12 and Glp-1 (Lambie & Kimble 1991). 
RNAi of known modulators of Notch were tried in lag-2(q420) to test for the 
viability of the assay. The results suggest that it might be feasible to look at enhancement 
of the Lag phenotype for positive modulators of LIN-12/GLP-1 signaling (figure 1A and 
figure 1B). Clones of erl-1 and the glucose transporters, H17B01.1, F53H8.3 and 
R09B5.11, were used to enhance lag-2(q420) at 15°C. RNAi against erl-1 was able to 
enhance lag-2(q420) in an RNAi sensitized background, at a level that was statistically 
significant and at the same level as RNAi against hop-1 or sel-12. For the glucose 
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transporters, the results were more complicated: although, clone H17B01.1 did not seem 
to enhance the Lag phenotype to the same extend as hop-1 or sel-12 RNAi, one of its 
paralogues, F53H8.3, did enhance the Lag phenotype (figure 1C). 
To validate that the RNAi results, especially the enhancement of lag-2(q420), we 
used an allele of erl-1; erl-1(tm2703), which is a deletion that removes exon 2, exon 3, 
and part of exon 4, and is likely to be a null. The erl-1(tm2703); lag-2(q420) double 
mutant did not have an enhanced Lag phenotype compared with lag-2(q420) alone 
(figure 1D), suggesting the lag-2 enhancement assay might be misleading. This result 
caused a re-evaluation of the lag-2(q420) assay and also a re-evaluation of the general 
approach taken. 
Positive modulators of GLP-1/Notch: 
 
With issues in the Lag RNAi enhancement assay and our RNAi library, we 
decided to do genetic experiments with the alleles of the other genes identified in the 
Wakabayashi list. Of the 46 C. elegans genes that are homologous with Wakabayashi set 
(table 1), 31 have available alleles. Of these, 20 genes have alleles that are viable or semi-
viable, of which 17 are either confirmed null or putative null. The other 3 are either 
temperature-sensitive conditional alleles or loss-of-function alleles. 4 of the 20 genes are 
linked to glp-1 and thus were not tested. As sensitized backgrounds, we used glp-
1(ar202), a gain-of-function allele and glp-1(bn18), a loss-of-function allele. Both glp-1 
alleles are temperature sensitive. 
The initial assay was to test for suppression of sterility cause by the glp-1(ar202) 
gain-of function allele at 25 °C. However, we later realized that out-crossing the glp-
1(ar202) lab strain into the same background strain used to create the doubles with glp-
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1(ar202) caused an increase in the number of worms that laid an egg or oocyte, even 
though the average number of eggs/oocytes were quite small (table 4). Out of the 16 
genes screened, 5 alleles suppressed glp-1(ar202) sterile phenotype above the 
background (table 5). Reassuringly, erl-1(tm2703) and H17B01.1(tm3165), which were 
recovered from the RNAi screen, were able to suppress glp-1(ar202) in this assay (table 
5). Furthermore, the RNAi results indicate that the suppression in the double mutant is 
unlikely to reflect genetic background issues. The genes sec-22(ok3053), cdc-
48.1(tm544), and goa-1(n363) were also capable of suppressing glp-1(ar202) sterility to a 
level above background (table 5), an effect also seen when looking at average brood size 
of the double mutants (table 5). Attempts to verify these results with RNAi to knockdown 
sec-22, cdc-48.1 and goa-1 were inconclusive (table 6). 
Next, we checked whether any of the possible candidates could enhance a loss-of-
function allele of glp-1. The allele glp-1(bn18) is a temperature sensitive mutation, which 
is fertile at 15 °C and 20 °C, but sterile at 25 °C (Kodoyianni et al. 1992; Dunn et al. 
2010). None of the tested genes enhance glp-1(bn18) sterility at 20 °C to a high 
confidence level (table 7).  
 There are many cell fate choices during embryogenesis that require GLP-1/Notch 
signaling, such that a loss of Notch signaling results in embryonic lethality (Priess et al. 
1987; Mello et al. 1994; Mickey et al. 1996). To investigate potential roles of the 
presenilin interactors in GLP-1/Notch signaling in embryonic development, double 
mutants with glp-1(bn18) were scored for enhanced embryonic lethality at 20 °C. At 20 
°C glp-1(bn18) has about 5% embryonic lethality phenotype. Of the alleles tested 
R09B5.11(ok1759), gpa-16(it143) and goa-1(n363) showed an enhancement of 
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embryonic lethality in combination with glp-1(bn18) (table 7 and table 8). Strains that 
were doubly homozygous with glp-1(bn18) and F53H8.3(ok3175), atgp-1(ok388), rab-
11.2(tm2081), or tsp-9(tm378) showed a level of embryonic lethality higher than that of 
glp-1(bn18) alone (table 7). However, this was due entirely to the alleles themselves, as 
the starting strains of F53H8.3(ok3175), atgp-1(ok388), rab-11.2(tm2081), and tsp-
9(tm378) had embryonic lethality at the same level as the doubles with glp-1(bn18) (table 
8). 
Negative regulators of GLP-1/Notch: 
 
It is possible that the presenilin interactors from the Wakabayashi list inhibit γ-
secretase activity and thus would negatively regulate Notch signaling. To test for 
negative regulators of GLP-1/Notch in C. elegans, suppression of glp-1 loss-of-function 
phenotypes were assayed both in the germline and in the embryo. 
To test for negative regulators of GLP-1/Notch in the germline, fertility was 
scored at 23°C. In this condition, glp-1(bn18) is about 48.6% fertile (table 9). In this 
assay, none of the tested alleles enhanced the glp-1(bn18) sterile phenotype (table 9).  
At 23°C, glp-1(bn18) has about a 99% embryonic and larval lethality (table 9). In 
this assay, the rab-11.2(tm2081); glp-1(bn18) strain is viable at 23°C, where 61% of the 
embryos laid make it to adult stage (table 9). This is compared to the level of suppression 
by sel-10(ok1632), which suppresses glp-1(bn18) embryonic lethality by 9.5 % (table 9). 





I have tested many genes that were reported to be associated with the γ-secretase 
complex in a mammalian tissue culture system (Wakabayashi et al. 2009). There have 
been other Presenilin interactors characterized biochemically, which I have not tested in 
this work (reviewed in Parks & Curtis 2007). There is little overlap between the proteins 
identified by Wakabayashi et al. and other work showing protein interactions with 
Presenilin (Parks & Curtis 2007). I chose the Wakabayashi list as the purification of the 
γ-secretase complex revealed a role of tetraspanins in γ-secretase function. This 
corroborated the genetic evidence that suggested the role of tetraspanins in Notch 
processing during the γ-secretase step (Dunn et al. 2010).  
However, it is possible that some of the proteins identified in the PS pull-down 
are not relevant to Presenilin activity. There are three possible sources of false positives 
in the study in Wakabayashi et al. First, the proteins identified by mass-
spectrophotometry were purified from solubilized membranes associated with PS1 or 
PS2. Solubilization of membranes was achieved by cold treatment with a mild detergent, 
which should solubilize individual protein units (Speers & Wu 2007). However, there are 
membranes that are resistant to complete solubilization by mild detergents, these have 
been termed Detergent Resistant Membranes (DRM) and are thought to be representative 
of cellular membrane structures called lipid rafts (Lingwood & Simons 2010). 
Furthermore, the γ-secretase complex is associated with these detergent resistant 
membranes (Wahrle et al. 2002; Wakabayashi et al. 2009). Thus, it is possible that some 
of the identified proteins in Wakabayashi et al. interact indirectly with Presenilin as part 
of these lipid rafts. 
97
	  
Second, the purification of the γ-secretase complex relied on expression of 
transgenic Presenilins. Studies have shown that transgenically expressed Presenilins 
differ in subcellular localization from the endogenous Presenilins (reviewed in Haass & 
De Strooper 1999). This might affect the proteins or membrane compartments that are 
associated with the overexpressed Presenilins. For example, studies of overexpressing 
transmembrane proteins elicited a stress response which caused the formation of 
aggresomes due to misfolded proteins (Johnston et al. 1998). However, in the 
Wakabayashi study there was a control purification using a distant paralogue to the 
Presenilins, SPPL-3 (Wakabayashi et al. 2009). This control purification should filter out 
any proteins that were recovered due to the overexpression of a transmembrane protein. 
As Presenilin is mostly localized to the ER and the Golgi compartments, it is 
likely that it is not in the γ-secretase complex. This is evidenced by the finding that there 
is a significant amount of full-length Presenilin in the purified fractions (Wakabayashi et 
al. 2009). As Presenilin undergoes endoproteolysis upon γ-secretase complex formation 
and activation, the presence of full-length Presenilin in the purified fraction suggests that 
some of the Presenilin purified is not in the γ-secretase complex and it is not in an active 
state. Thus, proteins isolated in the purification of Presenilin could be interacting with the 
Presenilin subunit in the ER or in the trafficking of Presenilin through the secretory 
pathway. These proteins might not be involved in γ-secretase activity and they would be 
unlikely to be involved in substrate recognition. 
The Presenilin pull down isolated large proteolipid structures, such as the 
tetraspanin web and lipid rafts (Wakabayashi et al. 2009). As a result the interactions 
might uncover direct protein-protein interactions or indirect interactions as part of the 
98
	  
tetraspanin web and lipid rafts. These indirect interactions could be important for γ-
secretase function, they could mark the sub-cellular location of the Presenilin, or they 
could be coincidental as part of the tetraspanin web or lipid rafts. 
If the points discussed above are true, any genetic interaction between the 
Wakabayashi list and glp-1 that is uncovered does not indicate a role in Presenilin 
activity per se. Further analysis would have to be done to determine whether such genetic 
interactions involve γ-secretase activity. 
The allele specificity of the positives suggests that these genes are not core 
components of Notch signaling pathway. I would expect that the core components of the 
Notch pathway would interact with both the glp-1(ar202), gain-of-function allele and 
glp-1(bn18), loss-of-function allele. However, there is a possibility that these genes could 
still be core components of Notch in C. elegans due to the potential of genetic and 
functional redundancy. Here, I outline the positive results and the potential effect they 
have on GLP-1 signaling in C. elegans. 
Goalpha: 
 
GOA-1 is a member of the alpha subunit of the heterotrimeric G-protein family. 
The heterotrimeric G-protein consist of three subunits, the α, β and γ subunits. The 
complex exists as a functional dimer where the Gα subunit associates with Gβγ dimer. 
Signal transduction can occur through either the Gα or Gβγ subunits. Downstream 
effectors of the heterotrimeric G-protein affect many different cellular processes. Gα0, 
which is GOA-1 in C. elegans, regulates ion channels and transporters, transcriptional 
machinery and the secretory pathway (reviewed in Neves et al. 2002). 
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Antibody staining of GOA-1 in dissected gonads shows expression in sheath cell 
and spermatheca (Govindan et al. 2006). It is involved in oocyte maturation and it 
inhibits meiotic progression until the Major Sperm Proteins are present (Govindan et al. 
2006; Cheng et al. 2008). The mechanism of GOA-1 on oocyte maturation is through the 
regulation of the gap junctions between the sheath cell and oocyte (Govindan et al. 2006). 
Loss of goa-1 leads to higher oocyte maturation rates and this is thought to occur by the 
loss of the gap junctions between sheath cell and oocyte (Govindan et al. 2006). 
Perhaps in glp-1(ar202) animals gap junctions still form between the proximal 
sheath and the proximal tumor. Removing GOA-1 activity from the sheath and 
spermatheca causes the gap junctions not to form, which inhibits tumorogenesis of the 
proximal gonad. As it has been shown, removal of the gonadal sheath cell and 
spermatheca by ablation can lead to the suppression of glp-1(ar202) proximal tumor 
(Killian & Hubbard 2005). Thus, it is possible that removing GOA-1 activity is inhibiting 
sheath cell or spermathecal function. 
CDC-48/p97:  
 
CDC-48 is a highly conserved family of ubiquitin-selective chaperones which 
contain an AAA-ATPase domain. Their key function is to unfold proteins and 
disassemble protein complexes. CDC-48/p97 has been shown to play critical roles in a 
broad range of diverse cellular processes in yeast, C. elegans, Drosophila and mammals. 
These processes include the Golgi, ER, and nuclear membrane reassembly, ERAD, the 
ubiquitin-proteasome system, cell cycle regulation, DNA repair, autophagosome 
maturation and mitophagy (reviewed in Yamanaka et al. 2011).  
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The expression pattern of cdc-48.1 cannot distinguish the autonomy of CDC-48.1 
in the suppression of glp-1(ar202). In-situ hybridization of cdc-48.1 and cdc-48.2 shows 
mRNA expression in the germline of L4 and adult hermaphrodites (Yamauchi et al. 
2006). Analysis of the amount of mRNA transcribed per paralogue suggested that cdc-
48.1 was transcribed two-fold higher than cdc-48.2. Translational fusion constructs with 
CDC-48.1 shows protein expression in the embryos and spermatocytes in the L4 stage 
and spermatheca in the adult (Yamauchi et al. 2006). 
 In C. elegans cdc-48.1 and cdc-48.2 function with sel-11(or hrd-1) in the UPR 
and ERAD pathways (Sasagawa et al. 2009). The suppression of glp-1(ar202) by cdc-
48.1 is probably not by a UPR pathway, as the knock down of cdc-48.1 would lead to 
stability glp-1(ar202) and thus, it should enhance its tumorous phenotype. This expected 
phenotype would be consistent with sel-11 suppressing a loss-of-function extracellular 
glp-1 mutation, glp-1(e2142) (Sundaram & Greenwald 1993).  
In C. elegans double knockdown of cdc-48.1 and cdc-48.2 cause an embryonic 
lethal phenotype. The main characteristic of the double knockdown is the appearance of 
numerous vacuoles in the embryo (Yamanaka et al. 2004). This might be suggestive of a 
defect in the secretory pathway.  
Given the genetic redundancy of cdc-48.1 and cdc-48.2 in the germline and the 
expression pattern of CDC-48.1 translational fusion it is possible that the deletion of cdc-
48.1 is having an effect through limiting secretion of a factor from the sheath cell or 
spermatheca. The DSL ligands APX-1 and ARG-1 are expressed in the proximal sheath 
cells and spermathecal cells (McGovern et al. 2009). Ablation of these cells can suppress 
the Pro phenotypes of glp-1(ar202) (Killian & Hubbard 2005). It is possible that 
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impairment in the secretory pathway may lead to loss of DSL ligand in the signaling cells 
and suppression of Notch signaling. 
ERLIN: 
 
The two Erlins in Mammals, Erlin1 and Erlin2, were first identified in 
mammalian culture systems as being enriched in lipid rafts from the ER (Browman et al. 
2006). Spfh2 (Erlin2) was identified as being required for degradation and ubiquitination 
of IP3 receptors in the ER (Pearce et al. 2007). Erlin2 functions along with other ERAD 
pathway components such as Hrd1/SEL-1 and p97/CDC-48 in the degradation of IP3R 
(Pearce et al. 2007). Both Erlin1 and Erlin2 recognize and bind to IP3R and target it to the 
ERAD pathway (Wang et al. 2009).  
There is no known function of C. elegans erlin, erl-1. Antibody staining shows 
that ERL-1 is expressed in the germline and in embryos (Hoegg 2010). The null mutant 
of erl-1 is completely viable. The association of mammalian Erlin2 and p97, suggests that 
C. elegans erl-1 and cdc-48.1 function in the same or related pathways. The suppression 
of glp-1(ar202) by loss of erl-1 could be similar to that of cdc-48.1 (see above). 
SEC-22: 
 
In yeast and mammals, Sec22p, a vSNARE, is involved in both the anterograde 
and retrograde ER to Golgi transport (Sacher et al. 1997; Ballensiefen et al. 1998; Liu & 
Barlowe 2002; Liu & Barlowe 2002; Ballensiefen et al. 1998; Sacher et al. 1997).  
In C. elegans the expression pattern has not been well characterized. According to 
the NEXTDB it might be expressed in the proximal gonad by in-situ hybridization, 
although the staining is very weak (NEXTDB, The Nematode Expression Pattern 
102
	  
DataBase at nematode.lab.nig.ac.jp). Although, the expression pattern of sec-22 is not 
well characterized, the observation that loss of sec-22 is able to suppress glp-1(ar202), 
but has no effect on glp-1(bn18) indicates the possibility of sec-22 functioning in the 
proximal gonad. If so, the effect of sec-22 on glp-1(ar202) could be similar to that of cdc-
48.1 on the proximal tumor of glp-1(ar202) animals. 
Sec22p forms a SNARE complex with Syntaxin-5 to mediate vesicle trafficking 
in the early secretory pathway (Dorer et al. 2006). Furthermore, Syntaxin-5 is associated 
with p97 in Golgi reassembly process (Rabouille et al. 1998). It is possible that sec-22 
and cdc-48.1 are involved in the same pathway in the ER to Golgi trafficking.  
An analogous protein to CDC-48, NSF which have been shown to affect Notch 
signaling at wing margin in Drosophila and involves the SNARE component syntaxin-1 
(Stewart et al. 2001). NSF and syntaxin-1 are involved in fusing vesicles from the Golgi 
to the plasma membrane. It is possible that CDC-48/p97, Sec-22p and Syntaxin-5 are 
playing an analogous role in the early secretory pathway in ER to Golgi trafficking. In 
these cases, improper export of the Notch to the plasma membrane is sufficient to 
knockdown Notch activity.  
Glucose Transporters: 
 
It has been shown that glucose starvation in mammalian tissue culture cells results 
in decrease expression of the growth-factor IL3-Rα at the cell surface (Wellen et al. 
2010). This observation was the result of decrease in glycosylation of the growth-factor 
receptor. Addition of downstream intermediate, GlnNAc, in the hexosamine pathway 
restored cell surface expression IL3-Rα (Wellen et al. 2010). Thus, cellular glucose levels 
can modulate the activity of cell-surface receptors through the glycosylation pathway. 
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GLP-1/Notch is highly glycosylated and defects in Notch glycosylation decrease 
its activity (reviewed in Stanley 2007). Therefore, it is possible that the knockdown of a 
glucose transporter is negatively affecting the presentation of GLP-1 to the cell surface or 
the activity of GLP-1. It also has been reported that the DSL ligands are also glycosylated 
and this could have an effect on DSL ligand function (Panin et al. 2002).  
H17B01.1 is expressed strongly in the proximal gonad, possibly the sheath cells 
and spermatheca (NEXTDB; http://nematode.lab.nig.ac.jp/db2/ShowCloneInfo.php?clone=567d8). 
There are two possibilities of how the glucose transporter is affecting GLP-1 activity in 
the proximal germline. If the sheath cell and spermatheca are influencing the proximal 
tumor in glp-1(ar202) animals through the gap junctions, it is possible that glucose is 
being delivered to the tumor via these gap junctions. It is also possible that glycosylation 
of the DSL ligands are necessary for proper ligand function. 
RAB-11: 
 
RAB-11 is a member of the Rab family of small GTPases. Members of this 
family have been shown to be involved in trafficking of membrane vesicles throughout 
the cell (reviewed in Stenmark & Olkkonen 2001). In Mammals, Rab11a is thought to 
promote the trafficking of vesicles from the trans-Golgi Network to the plasma 
membrane and is involved in the recycling endosomes (Stenmark & Olkkonen 2001). In 
Drosophila, Rab11 positively regulates Notch signaling in asymmetric cell division of the 
SOP by recycling the Delta ligand back to the plasma membrane (Emery et al. 2005). 
Although, this is unlikely to be happening in this situation as it appears that rab-11.2 is 
negatively regulating Notch in the C. elegans embryo. 
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It has been shown that blocking endosomal trafficking in Drosophila can lead to 
up-regulation of Notch activity (Jaekel & Klein 2006; Moberg et al. 2005; Thompson et 
al. 2005; Vaccari & Bilder 2005; Vaccari et al. 2008). This up-regulation of Notch is 
dependent on γ-secretase activity (Jaekel & Klein 2006). The requirement of RAB-11 in 
the recycling endosomes suggests that blockage of trafficking of Notch through the 
endosomes can increase Notch activity by aberrant activation by γ-secretase similar to 
what has been shown in D. melanogaster.  
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Chapter 3: Figures and Tables. 
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M. musculus Protein C. elegans Orthologues
Gene UniProt Entrez Gene Sequence Name (Gene) Gene Public Name
Anxa2 P07356 12306 C28A5.3 nex-3
ZC155.1 nex-1
Atp1a1 Q8VDN2 11928 B0365.3 eat-6
Atp2a2 O55143 11938 K11D9.2 sca-1
Atp6v0d1 P51863 11972 C30F8.2 vha-16
Atp6v1a P50516 11964 Y49A3A.2 vha-13
Cd47 Q61735 16423
Cd81 P35762 12520 C25G6.2 tsp-9
Ctnna1 P26231 12385 R13H4.4 hmp-1
Ctnnb1 Q02248 12387 C54D1.6 bar-1
K05C4.6 hmp-2
B0336.1 wrm-1













Got2 P05202 14719 C14F11.1 C14F11.1
C44E4.3 C44E4.3
Hspa8 P63017 15481 F26D10.3 hsp-1
Hspa9a P38647 15526 C37H5.8 hsp-6
Hspe1 Y22D7AL.10 Y22D7AL.10
Hspe1-rs1 Y22D7AL.10 Y22D7AL.10
Itga3 Q62470 16400 F54G8.3 ina-1
Itgb1 P09055 16412 ZK1058.2 pat-3
Ifitm3 Q9CQW9 66141
Igsf8 Q8R366 140559
Jup Q02257 16480 C54D1.6 bar-1
K05C4.6 hmp-2
B0336.1 wrm-1
Lman1 Q9D0F3 70361 K07A1.8 ile-1
Myadm O35682 50918
P4hb P09103 18453 C07A12.4 pdi-2
C14B1.1 pdi-1
Pdia3 P27773 14827 H06O01.1 pdi-3
Plp2 Q9R1Q7 18824 K09G1.1 K09G1.1
Ptgfrn Q9WV91 19221
Rab11a many 53869 W04G5.2 rab-11.2
F53G12.1 rab-11.1
Rab11b many 19326 W04G5.2 rab-11.2
F53G12.1 rab-11.1
Rpn2 Q9DBG6 20014 M01A10.3 M01A10.3
Sec22b O08547 20333 F55A4.1 F55A4.1
Serpinh1 P19324 12406
Slc2a1 P17809 20525 F53H8.3 F53H8.3
H17B01.1 H17B01.1
R09B5.11 R09B5.11
Slc3a2 P10852 17254 C38C6.2 atgp-2
F26D10.9 atgp-1
Slc38a2 Q8CFE6 67760
Slc7a5 Q9Z127 20539 F07C3.7 aat-2
Erlin1, Spfh1 226144 C42C1.15 C42C1.15
Erlin2, Spfh2 244373 C42C1.15 C42C1.15
Tmem109 Q3UBX0 68539
Tmed10 Q9D1D4 68581 F47G9.1 F47G9.1
Tmed2 Q9R0Q3 56334 W02D7.7 sel-9
Upk1b Q9Z2C6 22268
Vamp8 O70404 22320 B0513.9 B0513.9
Y69A2AR.6 Y69A2AR.6
Vcp Q01853 269523 C06A1.1 cdc-48.1
C41C4.8 cdc-48.2
Vdac1 Q60932 22333 R05G6.7 R05G6.7
LOC547349 - 547349
Table 1: Presenilin-associated proteins.


















































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































Suppression of sterility of glp-1(ar202): L1 hermaphrodites were fed RNAi containing bacte-
ria at 25.0 ºC. Three plates per RNAi clones were scored for the number of eggs and oocytes 
produced. Shown in the graph are the top three hits of the RNAi screen. Clones H17B01.1 and 
C42C1.15 show suppression of glp-1(ar202) above background. Each plate was scored as fol-
lows: (-) 1-25 eggs on a plate; (+) 26-50 eggs on a plate; (++) 51-100 eggs on a plate; (+++) 
>100 eggs on a plate.
RNAi clone Plate 1 Plate 2 Plate 3
FV + - -
GFP + - -
SUP-17 ++ ++ -
TSP-12 +++ +++ +++
GLP-1 +++ +++ +++
C42C1.15 ++ ++ +
H17B01.1 ++ ++ -
F53H8.3 ++ - -





























































































































































Figure 1: Enhancement of lag-2(q420).
A.) Enhancement of lag-2(q420): L4 hermaphrodites were fed RNAi containing bacteria at 15.0 
ºC. The number of progeny displaying the Lag phenotype were scored for each clone (n>300). 
Clones that showed suppression of glp-1(ar202) above background as well as paralogues for 
those clones. 
B.) Enhancement of lag-2(q420) in RNAi sensitizer backgrounds. L4 hermaphrodites were fed 
RNAi containing bacteria at 15.0 ºC. The number of progeny displaying the Lag phenotype were 
scored for each clone (n>300).
C.) Enhancement of lag-2(q420): L4 hermaphrodites were fed RNAi containing bacteria at 15.0 
ºC. The number of progeny displaying the Lag phenotype were scored for each clone (n>300). 
Clones that showed suppression of glp-1(ar202) above background as well as paralogues for 
those clones. 
D.) erl-1(tm2703) does not enhance lag-2(q420): L4 hermaphrodites were placed on plates on 
pre-calibrated at 15 °C, 20 °C and 25 °C. The number of progeny displaying the Lag phenotype 
were scored for each genotypes.
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GC143 glp-1(ar202) 1/344 (0.4 %) 0.0 ±0.16
GS5680c glp-1(ar202); him-5(e1490) 18/111 (16.2 %) 1.4 ±0.47
GS6212d glp-1(ar202) 42/118 (35.6 %) 2.5 ±0.40
GS6213d glp-1(ar202) 35/119 (29.4 %) 2.0 ±0.39
GS6214d glp-1(ar202) 38/117 (32.5 %) 2.2 ±0.45
GS6215d glp-1(ar202) 35/120 (29.2 %) 1.4 ±0.26
a Percent fertility scored at 25.1°C. Fertility scored as the presence of larvae, eggs or oocytes.
b Number of larvae, eggs or oocytes laid. The number of parents scored is indicated in the percent 
fertility column.
c  Strain GS5680 was used in the construction of all glp-1(ar202) containing strains.
d These glp-1(ar202) strains are derived from glp-1(ar202); him-5(e1490), strain: GS5680; and 
have been outcrossed to rhIs4 strain, GS4691.
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glp-1(ar202)c 38/117 (32.5 %) 2.2 ±0.45
sup-17(n1258); glp-1(ar202) 71/85 (83.5 %)# NDd
glp-1(ar202); adm-4(ok265) 56/59 (94.9 %)# NDd
glp-1(ar202); sel-12(ok2078)e 6/36 (16.7 %) 1.1 ±0.49
hop-1(ar179); glp-1(ar202) 4/25 (16.0 %) 0.9 ±0.61f
glp-1(ar202); erl-1(tm2703) 30/58 (51.7 %)* 5.7 ±1.23 #
H17B01.1(tm3165); glp-1(ar202) 33/57 (57.9 %)# 6.3 ±1.36#
glp-1(ar202); R09B5.11(ok1759) 16/53 (30.2 %) 3.1 ±1.04*
glp-1(ar202); F53H8.3(ok3175) 4/56 (7.1 %)# 0.4 ±0.28
H17B01.1(tm3165); glp-1(ar202);
 R09B05.11(ok1759); F53H8.3(ok3175) 32/59 (54.2 %)
* 3.8 ±0.62*
cdc-48.1(tm544); glp-1(ar202) 38/60 (63.3 %)# 5.2 ±1.05#
cdc-48.2(tm659); glp-1(ar202) 13/59 (22.0 %) 0.9 ±0.27
glp-1(ar202); atgp-1(ok388) 20/60 (33.3 %) 2.2 ±0.64
atgp-2(ok532); glp-1(ar202) 20/60 (33.3 %) 2.1 ±0.68
rab-11.2(tm2081); glp-1(ar202) 14/60 (23.3 %) 1.1 ±0.28
gpa-16(it143); glp-1(ar202) 22/59 (37.3 %) 2.1 ±0.57
glp-1(ar202); gpa-4(pk381) ND ND
goa-1(n363); glp-1(ar202) 52/60 (86.7 %)# 12.9 ±1.70#
glp-1(ar202); tsp-9(tm378) 17/60 (28.3 %) 2.4 ±0.61
glp-1(ar202); bar-1(ga80)  4/59 (6.8 %)# 1.1 ±0.78
glp-1(ar202); hmp-1(fe4) ND ND
glp-1(ar202); sec-22(ok3053) 24/39 (61.5%)# 9.6 ±2.29#
a Percent fertility scored at 25.1 °C. Fertility scored as the presence of larvae, eggs or oocytes. A 
two-tailed fisher’s exact test was done comparing to strain GS6214, glp-1(ar202). Key for statis-
tical test: * p<0.05; # p<0.00227 (Bonferroni correction for significance).
b Number of larvae, eggs or oocytes laid. The number of parents scored is indicated in the per-
cent fertility column. Student’s t-test was performed to ascertain statistical significance. Key for 
statistical test: * p<0.05; # p<0.00227 (Bonferroni correction for significance).
c Representative glp-1(ar202) strain, GS6214, that has been outcrossed to rhIs4 strain, GS4691, 
twice.
d 10 out 20 suppressed sup-17(n1258); glp-1(ar202) animals were Egl. Many of the suppressed 
glp-1(ar202); adm-4(ok265) hermaphrodites were Egl. Average brood-sizes were not scored for 
these two strains.
e The sel-12(ok2078) allele is a 1.5 kb deletion which removes part of the second exon and exons 
3-6.
f 1 out 4 hop-1(ar179); glp-1(ar202) suppressed animals was Egl. 
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Suppression of sterility of glp-1(ar202): L1 hermaphrodites were fed RNAi containing bacteria 
at 25.1 ºC. Five plates per RNAi clones were scored for the number of eggs and oocytes pro-
duced. Each plate was scored as follows: (-) 1-25 eggs on a plate; (+) 26-50 eggs on a plate; (++) 
51-100 eggs on a plate; (+++) >100 eggs on a plate.
RNAi clone Plate 1 Plate 2 Plate 3 Plate 4 Plate 5
GFP + + - - -
sup-17 +++ +++ ++ ++ ++
glp-1 +++ +++ +++ +++ +++
erl-1 +++ ++ ++ + +
H17B01.1 ++ ++ ++ ++ ++
cdc-48.1 ++ ++ + + -
sec-22 +++ + + - -
goa-1 ++ + + - -
Table 6: RNAi for positive regulators of Notch/GLP-1 in C. elegans. 
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glp-1(bn18)c 4/40 (10.0 %) N D
glp-1(bn18)d 5/239 (1.6 %) 54/1053 (5.1%)
glp-1(bn18); sup-17(n1258) 0/50 (0.0 %) 52/616 (8.4 %)*
glp-1(bn18); adm-4(ok265) 1/50 (2.0 %) 27/484 (5.6 %)
glp-1(bn18); sel-12(ok2078) 2/49 (4.1 %) 37/356 (10.4 %)
hop-1(ar179); glp-1(bn18) 40/99 (40.4 %)# 110/397 (23.8 %)#
glp-1(bn18); erl-1(tm2703) 2/49 (4.1 %) 20/526 (3.8 %)
H17B01.1(tm3165); glp-1(bn18) 3/50 (6.0 %) 88/1120 (7.9 %)
glp-1(bn18); R09B5.11(ok1759) 0/49 (0.0 %) 56/246 (22.8 %)#
glp-1(bn18); F53H8.3(ok3175) 1/35 (2.9 %) 27/240 (11.3 %)#
H17B01.1(tm3165); glp-1(bn18); R09B05.11(ok1759); F53H8.3(ok3175) 1/50 (2.0 %) 74/1018 (7.3 %)
cdc-48.1(tm544); glp-1(bn18) 0/50 (0.0%) 29/428 (6.8 %)
cdc-48.2(tm659); glp-1(bn18) 0/50 (0.0 %) 11/481 (2.3 %)
glp-1(bn18); atgp-1(ok388) 3/50 (6.0 %) 37/419 (8.8 %)
atgp-2(ok532); glp-1(bn18) 3/50 (6.0 %) 22/453 (4.9 %)
rab-11.2(tm2081); glp-1(bn18) 1/50 (2.0 %) 42/474 (8.9%)
gpa-16(it143); glp-1(bn18) 1/50 (2.0 %) 72/422 (17.1%)#
glp-1(bn18); gpa-4(pk381) ND ND
goa-1(n363); glp-1(bn18) 5/50 (10 %)* 232/925 (25.1%)#
glp-1(bn18); tsp-9(tm378) 0/50 (0.0 %) 51/618 (8.3 %)
glp-1(bn18); bar-1(ga80) 4/46 (8.0 %)* 28/450 (6.2 %)
glp-1(bn18); hmp-1(fe4) ND ND
glp-1(bn18); sec-22(ok3053) 0/50 (0.0 %) 22/400 (5.5 %)
a Percent sterility scored at 20 °C. Fertility scored as the presence of larvae, eggs or oocytes.  A 
two-tailed fisher’s exact test was done comparing to strain GS6232, glp-1(bn18). Key for statisti-
cal test: * p<0.05; # p<0.00227 (Bonferroni correction for significance).
b Emb phenotype score at 20 °C. L4 larvae were placed at 20 °C for 1 day, then transferred for to 
fresh plates. Emb, Lvl and Viable animals were scored after 2 days at 20 °C. A two-tailed fisher’s 
exact test was done comparing to strain GS6232, glp-1(bn18). Key for statistical test: * p<0.05; 
# p<0.00227 (Bonferroni correction for significance).
c Strain GC388, glp-1(bn18).
d Strain GS6232, glp-1(bn18), that has been outcrossed to rhIs4 strain, GS4691, twice.
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GS4691 rhIs4 30/540 (5.6 %)
GS6179 H17B01.1(tm3165); rhIs4s 61/976 (6.3 %)
GS6177 rhIs4; R09B5.11(ok1759) 42/675 (6.2 %)
GS6178 rhIs4; F53H8.3(ok3175) 53/880 (6.0 %)
GS6181 H17B01.1(tm3165); rhIs4; R09B05.11(ok1759); F53H8.3(ok3175) 65/874 (7.4 %)
GS6061 rhIs4; atgp-1(ok388) 35/377 (9.3 %)
GS6063 rab-11.2(tm2081); rhIs4 78/854 (9.1 %)
GS6192 gpa-16(it143); rhIs4 60/820 (7.3 %)
GS6193 goa-1(n363); rhIs4 25/350 (7.1 %)
GS5814 rhIs4; tsp-9(tm378) 63/541 (11.6 %)
a Emb phenotype score at 20 °C. L4 larvae were placed at 20 °C for 1 day, then transferred for to 
fresh plates. Emb, Lvl and Viable animals were scored after 2 days at 20 °C.
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glp-1(bn18)c 74/144 (48.6 %) 3/265 (1.13 %)
glp-1(bn18); sel-10(ok1632) ND 15/159 (9.43 %)#
glp-1(bn18); erl-1(tm2703) 17/35 (48.6 %) 0/283 (0.00 %)
H17B01.1(tm3165); glp-1(bn18) 18/36 (50.0 %) 0/256 (0.00 %)
glp-1(bn18); R09B5.11(ok1759) 12/35 (34.3 %) 6/102 (5.88 %)*
glp-1(bn18); F53H8.3(ok3175) 10/36 (27.8 %) 2/175 (1.14 %)
H17B01.1(tm3165); glp-1(bn18); R09B05.11(ok1759); F53H8.3(ok3175) 14/36 (38.9 %) 1/264 (0.38 %)
cdc-48.1(tm544); glp-1(bn18) 14/35 (40.0 %) 0/169 (0.00 %)
cdc-48.2(tm659); glp-1(bn18) 18/36 (50.0 %) 1/170 (0.59 %)
glp-1(bn18); atgp-1(ok388) 7/36 (19.4 %)# 1/227 (0.44 %)
atgp-2(ok532); glp-1(bn18) 13/36 (36.1 %) 1/189 (0.53 %)
rab-11.2(tm2081); glp-1(bn18) 11/35 (31.4 %) 150/245 (61.22 %)#
gpa-16(it143); glp-1(bn18) 9/36 (25.0 %)* 0/193 (0.00 %)
glp-1(bn18); gpa-4(pk381) ND ND
goa-1(n363); glp-1(bn18) 8/36 (22.2 %)* 0/275 (0.00 %)
glp-1(bn18); tsp-9(tm378) 8/36 (22.2 %)* 1/227 (0.44 %)
glp-1(bn18); bar-1(ga80) ND ND
glp-1(bn18); hmp-1(fe4) ND ND
glp-1(bn18); sec-22(ok3053) 12/33 (36.4 %) 0/192 (0.0 %)
a Percent sterility scored at 23.0 °C. Fertility scored as the presence of larvae, eggs or oocytes. A 
two-tailed fisher’s exact test was done comparing to strain GS6232, glp-1(bn18). Key for statisti-
cal test: * p<0.05; # p<0.00263 (Bonferroni correction for significance due to multiple testing).
b Emb phenotype score at 23.0 °C. L4 larvae were placed at 23.0 °C for 1 day, then transferred 
for to fresh plates. Emb, Lvl and Viable animals were scored after 2 days at 23.0 °C. A two-tailed 
fisher’s exact test was done comparing to strain GS6232, glp-1(bn18). Key for statistical test: * 
p<0.05; # p<0.00263 (Bonferroni correction for significance due to multiple testing).
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Erlin NA erl-1 decrease 0











p24a decrease sel-9 NA NA
EWI-F decrease NA NA NA
EWI-2 decrease NA NA NA
MYADM decrease NA NA NA
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  In this thesis I describe two separate projects. In Chapter 2, I describe an attempt 
to use φC31 integrase to insert transgenes in the C. elegans genome. Discussion of this 
technique is contained within Chapter 2. In brief, I showed that φC31 is active in C. 
elegans somatic cells. I also show that RMCE using injected φC31 mRNA is rare in the 
germline. I will briefly comment on the potential importance of this method and how it 
can be improved in this Chapter. 
In Chapter 3, I use genetic analysis to test many genes that were reported to be 
associated with the γ-secretase complex in a mammalian tissue culture system as to 
whether they modulate Notch in C. elegans (Wakabayashi et al. 2009). I have identified 
several genes that suppress a glp-1(gf) allele and one gene that suppresses a glp-1(lf) 
allele.  
In this Chapter, I discuss why these genes are unlikely to be core components of 
Notch signaling. I also discuss some of the questions that arose in the course of 
conducting experiments on the Wakabayashi list. These issues include genetic 
background, allele specificity and soma-to-germline interactions. Finally, I discuss what 
experiments could be done to screen for novel modulators of Presenilin.  
Discussion: 
φC31 potential uses and future prospects: 
  
 Even though I have not had much success with φC31 integration, I believe it is 
still important to pursue the method as means to achieve single copy insertion. In Chapter 
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2, I show that φC31 integrase is active in C. elegans. I also have been able to achieve 
integration into the genome using φC31 integrase via mRNA germline injections. The 
issue now is one of optimizing the method to make it a viable alternative to MosSCI, 
which has an integration efficiency of around 10 percent (Frøkjaer-Jensen et al. 2008). In 
order to have high integration efficiency I have attempted to integrate a germline 
expressing φC31 transgene using MosSCI. I have not been able to test whether this can 
increase φC31 mediated integration efficiency to a suitable level. It is important to test 
these strains in order to determine whether this method is viable. 
 It might be that φC31 cannot mediate integration of transgenes into the genome at 
a frequency that would make it attractive for use in C. elegans. In this case, φC31 could 
be used in a similar fashion to Flp/FRT and like the Flp/FRT method it could be used to 
manipulate transgenes in vivo. For example, one could mark cell lineages by expressing 
φC31 from a transiently expressing promoter, causing expression of a marker of choice. 
This marker of choice could be a fluorescent protein or one could misexpress a gene 
throughout a lineage as well to study gene function. Perhaps a more useful technique 
would be to conditionally knockout out an essential gene to study its role in 
developmental processes. 
Genetics and potential issues: 
 
The work in Chapter 3 highlights some issues with genetic analysis. Careful 
consideration of genetic background is important in determining the extent of genetic 
interactions uncovered. In the case of the work presented in Chapter 3, outcrossing the 
original glp-1(ar202) strain into a new genetic background, which was similar to the 
genetic background used in the double mutant strains, resulted in an increase in the 
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percentage of hermaphrodites that were scored as fertile compared to the original glp-
1(ar202) strain (see Chapter 3, table 4). The effect of genetic background is also seen in 
the glp-1(bn18) assay, where the level of sterility of the original glp-1(bn18) strain is 
higher than the out-crossed glp-1(bn18) strain at the non-permissive temperature (see 
Chapter 3, Table 5).  
There are two possible explanations for these observations. It is possible that there 
is a mutation in a positive regulator of Notch in the original glp-1(ar202) and glp-1(bn18) 
strains, which was removed during strain construction. Another possibility is that there is 
a mutation in a negative regulator of glp-1 introduced during construction of the rhIs4 
strains that confers a mild effect on glp-1 phenotypes. As the glp-1(ar202) and glp-
1(bn18) alleles were isolated in different laboratories, it is more probable that the 
modifier is coming from the rhIs4  strains. There was no attempt to isolate the potential 
modifier of glp-1.  
Difference in assay types: 
 
 In wild-type animals, the site of action of glp-1 is in the distal germline to 
maintain a population of mitotic germ cells. The proximal tumor in glp-1(ar202) is 
maintained throughout development due to the expression of DSL ligands proximally, 
first  lag-2 in the AC, and then apx-1 and arg-1 in the sheath cell (Pepper, Killian & 
Hubbard 2003b; McGovern et al. 2009). In some glp-1(ar202) animals with proximal 
tumors, oogenesis can still occur normally, although oocytes appear to be blocked by the 
proximal tumor from further development (Pepper, Killian & Hubbard 2003b). As the 
glp-1(ar202) suppression assay was based on the ability of the animal to produce eggs, it 
is a proxy for measuring proximal tumor formation or severity. The proximal tumor is in 
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a different environment than the distal proliferating cells, as the proximal tumor is 
surrounded by sheath cells and exposed to potential signaling molecules from the sheath 
cells; thus it is possible that the glp-1(ar202) assay used in this work would uncover 
genes not normally involved in the glp-1 mediated maintenance of the distal mitotic zone. 
Instead, it could uncover genes involved in the maintenance of the proximal tumor, which 
might involve the communication between the sheath cell and the proximal tumor (see 
Chapter 3 Discussion, and below).  Although, it must be noted that this assay has been 
successful at uncovering Notch modulators (Jarriault & Greenwald 2005; Dunn et al. 
2010). 
The differences in the assay might contribute to a different outcome in the screen. 
For example glp-1(ar202) assay depends on the ability to lay eggs: the proximal tumor 
impedes oogenesis progression. I have not measured the degree of suppression of the 
proximal tumor, which might be a better assessment of Notch suppression (Pepper, 
Killian & Hubbard 2003b). I also did not measure the effects of mutations on the extent 
of distal germline proliferation, which would be easier to compare with glp-1(bn18) loss-
of-function assays. 
 In the glp-1(bn18) loss-of-function assays we measured an all-or-nothing 
response. Any subtle defects in germline proliferation would have been missed. A more 
careful assessment of germline proliferation could be done by either measuring the 
number of progeny laid per animal or by measuring the extent of germline proliferation in 
the distal mitotic zone (Pepper, Killian & Hubbard 2003b; Tian et al. 2004).  
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Differences in alleles: 
 
 The two glp-1 alleles used to test the various genes from the Wakabayashi list, 
have different biochemical and genetic properties, which could have a differential effect 
on the result of each assay.  
The glp-1(ar202) allele is a gain-of-function point mutation in the first Lin-
12/Notch Repeat (LNR) domain in the extracellular domain. As the LNR repeats are 
thought to shield the S2 cleavage site from the metalloproteases, mutations in these 
domains destabilize the LNR domains allowing access to the S2 cleavage site by the 
metalloproteases, triggering the release of the NICD from the membrane (Sanchez-
Irizarry et al. 2004; Gordon et al. 2009). In fact, many dominant mutations in both glp-1 
and lin-12 are found in the LNR repeats. These include: lin-12(n952), lin-12(n302), glp-
1(oz264), glp-1(oz274), glp-1(ar218) and finally glp-1(ar202) (Greenwald & Seydoux 
1990; Kerins 2006; Pepper, Killian & Hubbard 2003b).  
Mutations in the extracellular domain can elicit the unfolded protein response 
(UPR) as it is likely that these mutations can lead to a malfolded extracellular domain. 
One consequence of UPR, is the ER-associated degradation pathway (ERAD). Genes 
involved in the UPR and ERAD pathway have been uncovered in screens for suppressors 
and enhancers of lin-12, including sel-1 and sel-11 (Sundaram & Greenwald 1993; Grant 
& Greenwald 1996; Choi et al. 2010). These two genes are capable of suppressing loss-
of-function mutations in glp-1 when the mutation is in the extracellular domain but are 




The glp-1(bn18) mutation is an amino acid change A1034T in the ankyrin repeats 
of the intracellular domain. The ankyrin repeats mediates protein-protein contacts with 
the CSL protein LAG-1 and helps bind SEL-8 to form the tri-partite transcriptional 
complex. As the mutation is in the intracellular domain, it might not be subjected to UPR 
and ERAD. This might explain the different behavior of the mutants in the glp-1(ar202) 
assay and the glp-1(bn18) assay. However, it might be expected that a knockdown of a 
UPR or ERAD pathway component would result in an enhancement of glp-1(ar202). 
Thus, it is unlikely that the positive results in glp-1(ar202) suppression test are involved 
in UPR or ERAD as discussed in Chapter 3. 
 The glp-1(ar202) gain-of-function allele is somewhat independent of ligand 
activity for its germline phenotype as loss of ligand does not completely suppress the Pro 
phenotype. (Pepper, Killian & Hubbard 2003b; McGovern et al. 2009). On the other 
hand, the glp-1(bn18) loss-of-function allele is fully dependent on ligand activity as loss 
of DSL ligand’s ability to signal can have a dramatic impact on the Ste phenotype of glp-
1(bn18) (Tian et al. 2004). 
 A modulator of the Notch pathway would not be expected to be allele-specific: it 
should not differentiate between the different alleles, and should affect the allele specific 
phenotypes regardless of the nature of the allele. Thus, it is advantageous to test different 
alleles to determine the requirement of a gene for a pathway. 
Soma-to-germline interactions: 
 
 Here, I discuss the various ways that the somatic gonad can affect the germline 
and how that might influence the interpretation of the results from the modulators of glp-
1(ar202) assay.  
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In the case of the distal germline, that signal is coming from the distal tip cell 
(DTC). Ablation of the DTC results in the reduction of germline proliferation (Kimble & 
White 1981). As discussed in Chapter 1, the DTC expresses the DSL gene lag-2 and 
signals to the glp-1 expressing distal germline to promote proliferation. Defects in the 
DTC that might compromise LAG-2 function would be expected to enhance the loss-of-
function glp-1(bn18) allele. As none of the glp-1(ar202) suppressors enhanced glp-
1(bn18) sterility, it is unlikely that they are involved with ligand function at the DTC. 
Thus, it is possible that there are interactions between the proximal somatic gonad and 
the germline that is influencing glp-1(ar202) sterility. 
An interaction between the proximal somatic gonad and the germline was first 
seen in lin-12(0) animals, where a population of germ cells remained mitotically 
proliferating at the proximal end of the germline (Seydoux et al. 1990). The proximal 
tumor phenotype of lin-12(0) is dependent on the presence of the AC (Seydoux et al. 
1990). In a WT background, ablation of the somatic gonad except the AC leads to a Pro 
phenotype, phenocopying the lin-12(0) mutant animal. The Pro phenotype in these two 
cases was due to inappropriate contact between the DSL producing anchor cell (AC) and 
the proximal germline (Seydoux et al. 1990). In this case, the somatic gonad, including 
the SS lineage, is shielding the proximal germline from inappropriate activation of GLP-
1/Notch signaling by the AC. Furthermore, ablation of the AC can influence the timing of 
meiotic entry of the germline and can partially suppress the Pro phenotype of glp-
1(ar202) (Pepper, Lo, Killian, Hall, et al. 2003a). Due to the subtlety of effects on the 
germline by the AC, it is unlikely that the glp-1(ar202) suppressors are acting in the AC. 
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There is extensive signaling between the sheath cells/spermatheca and the 
germline. The sheath cells and the spermatheca arise from the SS cell; there are two SS 
cells per gonad arm (Chapter 1, figure 5). The proximal soma-to-germline interaction is 
more complicated as the ablation of the SS lineage results in several defects. Ablation of 
both SS cells at L2/L3 molt results in reduced germline proliferation and defects in the 
exit from the pachytene stage of meiotic prophase, while the ablation of one SS cell at 
L2/L3 molt can result in the failure of ovulation of mature oocytes and feminization of 
the germline (McCarter et al. 1997). 
Ablation experiments of the SS cells in a strain containing a constitutively active 
glp-1 allele, glp-1(oz112), suggests that either there is a signal emanating from the SS 
lineage that is independent of GLP-1 for germline proliferation or that the cells from the 
SS lineage are providing nutrition to the germline to maintain proliferation (McCarter et 
al. 1997). In addition, the SS lineage is required for the Pro tumor phenotype of glp-
1(ar202): specifically the ablation of the proximal sheath/spermatheca can suppress the 
Pro phenotype of glp-1(ar202) (Killian & Hubbard 2005). The DSL genes apx-1 and arg-
1 are expressed in the proximal sheath and spermatheca, thus it is possible that glp-
1(ar202) suppressors are having an effect on the ligand side of Notch signaling in the 
proximal sheath and/or spermatheca (Chapter 3, Discussion). 
 As I mention in the discussion section of Chapter 3, many of the positives are 
expressed in the proximal gonad, particularly the sheath cells and spermatheca. Thus 
these positives could be acting in ligand production or presentation of the ligand to the 
cell surface or sheath cell/spermatheca integrity and function. All of these could impact 
the extent of the proximal tumor, without affecting Notch signaling in the distal germline. 
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Assessing γ-secretase activity: 
 
In Wakabayashi et al. a subset of the proteins identified by the TAP-tag 
purification method were screened for an effect on APP processing. Along with CD9, 
CD81 and CD98hc a few others had an effect on APP processing by RNAi in their tissue 
culture system (Wakabayashi et al. 2009). There was significant overlap between the hits 
in the Wakabayashi et al. paper and the work presented in this chapter. However, several 
of the common hits have opposite effects from the genetic analysis done in Chapter 3 
(Chapter 3, table 10).  
The opposite effects between the two sets could be explained by the differences in 
the assays themselves. The RNAi assay in tissue culture is cell-autonomous and might 
truly reflect the association with presenilin or it might reflect the processing of APP 
itself. The glp-1 assays depend on coordinated signals within the developing and mature 
germline or in the embryo of C. elegans. 
 How might one design a better screen to uncover new modulators of presenilin 
activity in C. elegans? Forward genetic approaches such as the Sel, Aph and Pen screens 
have been quite successful in uncovering the components of the γ-secretase complex. 
Perhaps, taking the Aph and Pen screens to saturation would allow for identification of 
other γ-secretase modulators.  
A reverse genetic screen, which would rely on RNAi, could be done to screen for 
genes that are conserved between Humans and C. elegans that might modulate γ-
secretase activity. This could be based on phenotypic screens such as the Aph or Glp 
screens or could be based on modifier screens such as the Sel or Pen screens. However, 
phenotypic screens have not been used as much in identifying Notch components, as 
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modifier screens have been more successful (see Chapter 1). By using a lin-12(d) allele 
or better yet, using a lin-12(ΔE) transgene expressed in the VPCs, where disruption of γ-
secretase function would disrupt Notch signaling, a suppression screen might be 
preferable in identifying modulators of the γ-secretase complex. A sensitized background 
would need to be used to overcome the limitations of RNAi in the VPCs (Greenwald lab 
members, unpublished results).  
As the germline is more amenable to RNAi than the VPCs, it might be worth 
designing a screen to take advantage of that. As overexpressing a constitutive active form 
of glp-1 in the germline causes tumors, one could make a conditional glp-1(ΔE) with a 
temperature-sensitive mutation in the intracellular domain such as glp-1(bn18) or glp-
1(e2144) and insert the glp-1 transgene in the germline using single copy insertion 
techniques such as MosSCI to allow for expression in the germline. These strains should 
be wild type at 25 °C but tumorous and sterile at 20 °C and 15 °C. RNAi could be used to 
suppress the sterility and tumors of the strain at the lower temperatures. As this transgene 
is ligand independent, one would not need to worry about affecting ligand production and 
function, though such a screen should also pick-up components downstream of the γ-
secretase step in the Notch pathway. It might pick up other components required for the 
proliferation and maintenance of the germline as well. This would require further analysis 
to be sure that it is involved in Notch signal transduction and involved in γ-secretase 
activity.  
Alternatively, one could design a fluorescent artificial γ-secretase substrate, such 
that when the substrate is cleaved, the intracellular domain translocates to the nucleus. 
This would allow for a visual inspection of γ-secretase activity. Loss of γ-secretase 
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activity in this instance would be visualized by the retention of the fluorescent substrate 
at the cell surface. This of course assumes that fluorescent protein would be visible. 
Perhaps, these screens would find additional γ-secretase components, which could 
be tested in mammalian cell lines for γ-secretase in Notch signaling and Aβ production. 
These modulators could be target by drugs to disrupt γ-secretase activity to treat T-ALL 
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